10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the quarterly period ended October 28, 2023

or

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from ______ to ______

Commission file number 001-33731

METHODE ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware	36-2090085
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
8750 West Bryn Mawr Avenue, Suite 1000, Chicago, Illinois	60631-3518
(Address of principal executive offices)	(Zip Code)

(Registrant’s telephone number, including area code) (708) 867-6777

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.50 Par Value	MEI	New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At December 4, 2023, the registrant had 35,599,426 shares of common stock outstanding.

METHODE ELECTRONICS, INC.

INDEX

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Statements of Income (unaudited) - Three and Six Months Ended October 28, 2023 and October 29, 2022	2
	Condensed Consolidated Statements of Comprehensive Income (unaudited) - Three and Six Months Ended October 28, 2023 and October 29, 2022	3
	Condensed Consolidated Balance Sheets as of October 28, 2023 (unaudited) and April 29, 2023	4
	Condensed Consolidated Statements of Shareholders’ Equity (unaudited) - Three and Six Months Ended October 28, 2023 and October 29, 2022	5
	Condensed Consolidated Statements of Cash Flows (unaudited) - Six Months Ended October 28, 2023 and October 29, 2022	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35
Item 4.	Controls and Procedures	35
PART II.	OTHER INFORMATION
Item 1A.	Risk Factors	37
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37
Item 5.	Other Information	37
Item 6.	Exhibits	37
SIGNATURES		38

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(in millions, except per share data)

	Three Months Ended						Six Months Ended
	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales	$	288.0		$	315.9		$	577.7		$	598.3
Cost of products sold		235.7			241.8			471.4			462.4
Gross profit		52.3			74.1			106.3			135.9
Selling and administrative expenses		40.9			36.6			85.4			71.9
Goodwill impairment		56.5			—			56.5			—
Amortization of intangibles		6.2			4.7			11.9			9.4
(Loss) income from operations		(51.3	)		32.8			(47.5	)		54.6
Interest expense, net		4.4			0.5			7.2			0.5
Other income, net		(0.2	)		(1.1	)		(0.2	)		(5.2	)
Pre-tax (loss) income		(55.5	)		33.4			(54.5	)		59.3
Income tax (benefit) expense		(0.2	)		5.8			(0.1	)		10.2
Net (loss) income		(55.3	)		27.6			(54.4	)		49.1
Net income attributable to redeemable noncontrolling interest		—			—			—			—
Net (loss) income attributable to Methode	$	(55.3	)	$	27.6		$	(54.4	)	$	49.1
(Loss) income per share attributable to Methode:
Basic	$	(1.55	)	$	0.76		$	(1.52	)	$	1.35
Diluted	$	(1.55	)	$	0.75		$	(1.52	)	$	1.33
Cash dividends per share	$	0.14		$	0.14		$	0.28		$	0.28

See notes to condensed consolidated financial statements.

2

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in millions)

	Three Months Ended						Six Months Ended
	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net (loss) income	$	(55.3	)	$	27.6		$	(54.4	)	$	49.1
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments		(20.2	)		(19.7	)		(22.7	)		(30.6	)
Derivative financial instruments		0.4			1.6			(1.2	)		3.1
Other comprehensive loss		(19.8	)		(18.1	)		(23.9	)		(27.5	)
Comprehensive (loss) income		(75.1	)		9.5			(78.3	)		21.6
Comprehensive income attributable to redeemable noncontrolling interest		—			—			—			—
Comprehensive (loss) income attributable to Methode	$	(75.1	)	$	9.5		$	(78.3	)	$	21.6

See notes to condensed consolidated financial statements.

3

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per-share data)

	October 28, 2023			April 29, 2023
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	122.5		$	157.0
Accounts receivable, net		292.3			314.3
Inventories		183.9			159.7
Income tax receivable		16.7			12.9
Prepaid expenses and other current assets		21.1			20.5
Total current assets		636.5			664.4
Long-term assets:
Property, plant and equipment, net		224.6			220.3
Goodwill		220.7			301.9
Other intangible assets, net		264.7			256.7
Operating lease right-of-use assets, net		26.9			28.4
Deferred tax assets		33.0			33.6
Pre-production costs		44.5			36.1
Other long-term assets		34.0			37.7
Total long-term assets		848.4			914.7
Total assets	$	1,484.9		$	1,579.1
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	133.5		$	138.7
Accrued employee liabilities		29.0			36.7
Other accrued liabilities		38.7			34.5
Short-term operating lease liabilities		6.6			6.8
Short-term debt		3.0			3.2
Income tax payable		7.5			8.1
Total current liabilities		218.3			228.0
Long-term liabilities:
Long-term debt		329.0			303.6
Long-term operating lease liabilities		20.9			21.8
Long-term income tax payable		9.3			16.7
Other long-term liabilities		16.5			14.3
Deferred tax liabilities		46.0			41.8
Total long-term liabilities		421.7			398.2
Total liabilities		640.0			626.2
Redeemable noncontrolling interest		—			11.1
Shareholders' equity:
Common stock, $0.50 par value, 100,000,000 shares authorized, 37,034,050 shares and 37,167,375 shares issued as of October 28, 2023 and April 29, 2023, respectively		18.5			18.6
Additional paid-in capital		183.8			181.0
Accumulated other comprehensive loss		(42.9	)		(19.0	)
Treasury stock, 1,346,624 shares as of October 28, 2023 and April 29, 2023		(11.5	)		(11.5	)
Retained earnings		697.0			772.7
Total shareholders' equity		844.9			941.8
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$	1,484.9		$	1,579.1

See notes to condensed consolidated financial statements.

4

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited)

(in millions, except share data)

	Three Months Ended October 28, 2023
	Redeemable noncontrolling interest			Common stock shares			Common stock			Additional paid-in capital		Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of July 29, 2023	$	0.9			37,356,156		$	18.7		$	182.5	$	(23.1	)	$	(11.5	)	$	764.8		$	931.4
Issuance of restricted stock, net of tax withholding		—			673			—			—		—			—			—			—
Purchase of redeemable noncontrolling interest		(0.9	)		—			—			—		—			—			—			—
Purchases of common stock		—			(322,779	)		(0.2	)		—		—			—			(7.6	)		(7.8	)
Stock-based compensation expense		—			—			—			1.3		—			—			—			1.3
Other comprehensive loss		—			—			—			—		(19.8	)		—			—			(19.8	)
Net loss		—			—			—			—		—			—			(55.3	)		(55.3	)
Dividends on common stock		—			—			—			—		—			—			(4.9	)		(4.9	)
Balance as of October 28, 2023	$	—			37,034,050		$	18.5		$	183.8	$	(42.9	)	$	(11.5	)	$	697.0		$	844.9

	Three Months Ended October 29, 2022
	Redeemable noncontrolling interest		Common stock shares			Common stock			Additional paid-in capital		Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of July 30, 2022	$	—		38,001,714		$	19.0		$	172.0	$	(36.2	)	$	(11.5	)	$	768.1		$	911.4
Issuance of restricted stock, net of tax withholding		—		12,098			—			—		—			—			—			—
Purchases of common stock		—		(508,179	)		(0.3	)		—		—			—			(19.4	)		(19.7	)
Stock-based compensation expense		—		—			—			2.7		—			—			—			2.7
Other comprehensive loss		—		—			—			—		(18.1	)		—			—			(18.1	)
Net income		—		—			—			—		—			—			27.6			27.6
Dividends on common stock		—		—			—			—		—			—			(5.1	)		(5.1	)
Balance as of October 29, 2022	$	—		37,505,633		$	18.7		$	174.7	$	(54.3	)	$	(11.5	)	$	771.2		$	898.8

5

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited) (continued)

(in millions, except share data)

	Six Months Ended October 28, 2023
	Redeemable noncontrolling interest			Common stock shares			Common stock			Additional paid-in capital			Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of April 29, 2023	$	11.1			37,167,375		$	18.6		$	181.0		$	(19.0	)	$	(11.5	)	$	772.7		$	941.8
Issuance of restricted stock, net of tax withholding		—			189,454			0.1			(0.1	)		—			—			(3.8	)		(3.8	)
Purchase of redeemable noncontrolling interest		(11.1	)		—			—			—			—			—			—			—
Purchases of common stock		—			(322,779	)		(0.2	)		—			—			—			(7.6	)		(7.8	)
Stock-based compensation expense		—			—			—			2.9			—			—			—			2.9
Other comprehensive loss		—			—			—			—			(23.9	)		—			—			(23.9	)
Net loss		—			—			—			—			—			—			(54.4	)		(54.4	)
Dividends on common stock		—			—			—			—			—			—			(9.9	)		(9.9	)
Balance as of October 28, 2023	$	—			37,034,050		$	18.5		$	183.8		$	(42.9	)	$	(11.5	)	$	697.0		$	844.9

	Six Months Ended October 29, 2022
	Redeemable noncontrolling interest		Common stock shares			Common stock			Additional paid-in capital		Accumulated other comprehensive income (loss)			Treasury stock			Retained earnings			Total shareholders' equity
Balance as of April 30, 2022	$	—		38,276,968		$	19.2		$	169.0	$	(26.8	)	$	(11.5	)	$	763.9		$	913.8
Issuance of restricted stock, net of tax withholding		—		54,479			—			—		—			—			(0.4	)		(0.4	)
Purchases of common stock		—		(825,814	)		(0.5	)		—		—			—			(31.1	)		(31.6	)
Stock-based compensation expense		—		—			—			5.7		—			—			—			5.7
Other comprehensive loss		—		—			—			—		(27.5	)		—			—			(27.5	)
Net income		—		—			—			—		—			—			49.1			49.1
Dividends on common stock		—		—			—			—		—			—			(10.3	)		(10.3	)
Balance as of October 29, 2022	$	—		37,505,633		$	18.7		$	174.7	$	(54.3	)	$	(11.5	)	$	771.2		$	898.8

See notes to condensed consolidated financial statements.

6

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

	Six Months Ended
	October 28, 2023			October 29, 2022
Operating activities:
Net (loss) income	$	(54.4	)	$	49.1
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		28.4			24.5
Stock-based compensation expense		3.9			6.7
Change in cash surrender value of life insurance		(0.2	)		(0.2	)
Amortization of debt issuance costs		0.4			0.3
Loss on sale of assets		0.5			0.1
Impairment of long-lived assets		0.6			0.4
Goodwill impairment		56.5			—
Change in deferred income taxes		(1.0	)		1.0
Other		0.8			0.2
Changes in operating assets and liabilities:
Accounts receivable		12.5			(50.6	)
Inventories		(29.1	)		(19.5	)
Prepaid expenses and other assets		(10.8	)		(15.7	)
Accounts payable		(1.8	)		21.5
Other liabilities		(12.5	)		10.3
Net cash (used in) provided by operating activities		(6.2	)		28.1
Investing activities:
Purchases of property, plant and equipment		(24.5	)		(18.0	)
Proceeds from settlement of net investment hedge		0.6			—
Proceeds from disposition of assets		1.6			3.5
Net cash used in investing activities		(22.3	)		(14.5	)
Financing activities:
Taxes paid related to net share settlement of equity awards		(3.8	)		(0.5	)
Repayments of finance leases		(0.1	)		(0.2	)
Purchases of common stock		(7.8	)		(31.6	)
Cash dividends		(10.1	)		(9.9	)
Purchase of redeemable noncontrolling interest		(10.9	)		—
Proceeds from borrowings		213.9			—
Repayments of borrowings		(179.3	)		(6.5	)
Net cash provided by (used in) financing activities		1.9			(48.7	)
Effect of foreign currency exchange rate changes on cash and cash equivalents		(7.9	)		(7.3	)
Decrease in cash and cash equivalents		(34.5	)		(42.4	)
Cash and cash equivalents at beginning of the period		157.0			172.0
Cash and cash equivalents at end of the period	$	122.5		$	129.6
Supplemental cash flow information:
Cash paid during the period for:
Interest	$	6.7		$	1.4
Income taxes, net of refunds	$	14.5		$	12.5
Operating lease obligations	$	4.5		$	4.0

See notes to condensed consolidated financial statements.

7

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of business

Methode Electronics, Inc. (the “Company” or “Methode”) is a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. The Company designs, engineers and produces mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing its broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

The Company’s solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment and consumer appliance.

Basis of presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany balances and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair presentation of the results of operations, financial position and cash flows of the Company for the interim periods presented. These financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Form 10-K for the year ended April 29, 2023, filed with the SEC on June 27, 2023. Results may vary from quarter to quarter for reasons other than seasonality.

Financial reporting periods

The Company maintains its financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. The three months ended October 28, 2023 and October 29, 2022 were both 13-week periods and the six months ended October 28, 2023 and October 29, 2022 were both 26-week periods.

Use of estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. These estimates and assumptions are subject to an inherent degree of uncertainty and may change, as new events occur, and additional information is obtained. As a result, actual results may differ from previously estimated amounts, and such differences may be material to the condensed consolidated financial statements.

Recently adopted accounting pronouncements

In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, “Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Accounting Standards Codification ("ASC") 606, as if the acquirer had originated the contracts. Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. The Company adopted this ASU in the first quarter of fiscal 2024 on a prospective basis. The adoption of this ASU did not have a material impact on its condensed consolidated financial statements or related disclosures and is only applicable to future business acquisitions.

New accounting pronouncements not yet adopted

In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which requires public entities to disclose information about their reportable segments’ significant expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. Early adoption is permitted. The adoption of this ASU will result in increased disclosures for the Company's segments.

8

There have been no other newly issued or newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements. Further, at October 28, 2023, there are no other pronouncements pending adoption that are expected to have a material impact on the Company’s condensed consolidated financial statements.

Summary of significant accounting policies

The Company’s significant accounting policies are described in Note 1, “Description of Business and Summary of Significant Accounting Policies,” to the consolidated financial statements included in the Company’s Form 10-K for the year ended April 29, 2023. There have been no material changes to the significant accounting policies in the six months ended October 28, 2023.

Note 2. Revenue

The Company generates revenue from manufacturing products for customers in diversified global markets. The substantial majority of the Company’s revenue is recognized at a point in time. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer’s usage.

Revenue associated with products which the Company believes have no alternative use (such as highly customized parts), and where the Company has an enforceable right to payment, are recognized on an over time basis. Revenue is recognized based on progress to date, which is typically even over the production process through transfer of control to the customer.

From time to time, customers may negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.

Across all products, the amount of revenue recognized corresponds to the related purchase order and is adjusted for variable consideration (such as discounts) and ongoing price adjustments. Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.

The Company’s performance obligations are typically short-term in nature. As a result, the Company has elected the practical expedient that provides an exemption from the disclosure requirements regarding information about remaining performance obligations on contracts that have original expected durations of one year or less.

Contract balances

A contract asset is an entity’s right to consideration in exchange for goods or services that the entity has transferred to a customer. A contract liability exists when an entity has received consideration, or the amount is due from the customer in advance of revenue recognition. The net changes in the contract asset and contract liability balances for the six months ended October 28, 2023 and October 29, 2022 were not material.

Disaggregated revenue information

The following table represents a disaggregation of revenue from contracts with customers by segment and geographical location. Net sales are attributed to regions based on the location of production. Though revenue recognition patterns and contracts are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.

	Three Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	70.9	$	52.0	$	11.7	$	1.5	$	136.1
Europe, the Middle East & Africa ("EMEA")		49.7		42.8		—		—		92.5
Asia		33.7		25.6		—		0.1		59.4
Total net sales	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0
Timing of revenue recognition:
Goods transferred at a point in time	$	149.9	$	120.4	$	11.7	$	1.6	$	283.6
Goods transferred over time		4.4		—		—		—		4.4
Total net sales	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0

9

	Three Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	97.8	$	40.1	$	14.0	$	1.1	$	153.0
EMEA		53.9		37.9		—		—		91.8
Asia		45.2		25.8		0.1		—		71.1
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9
Timing of revenue recognition:
Goods transferred at a point in time	$	192.3	$	103.8	$	14.1	$	1.1	$	311.3
Goods transferred over time		4.6		—		—		—		4.6
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9

	Six Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	137.7	$	92.0	$	26.9	$	2.3	$	258.9
EMEA		101.9		93.9		—		—		195.8
Asia		73.0		49.9		—		0.1		123.0
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7
Timing of revenue recognition:
Goods transferred at a point in time	$	304.1	$	235.8	$	26.9	$	2.4	$	569.2
Goods transferred over time		8.5		—		—		—		8.5
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7

	Six Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	192.5	$	80.8	$	27.0	$	1.8	$	302.1
EMEA		106.0		66.4		—		—		172.4
Asia		75.0		48.7		0.1		—		123.8
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3
Timing of revenue recognition:
Goods transferred at a point in time	$	364.4	$	195.9	$	27.1	$	1.8	$	589.2
Goods transferred over time		9.1		—		—		—		9.1
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3

Note 3. Acquisition and Disposition

Acquisition

On April 20, 2023, the Company acquired 92.2% of the outstanding shares in Nordic Lights Group Corporation (“Nordic Lights”), a premium provider of high-quality lighting solutions for heavy duty equipment headquartered in Finland, for €121.8 million ($134.2 million) in cash. Between May 2023 and July 2023, the Company acquired an additional 7.2% of the outstanding shares of Nordic Lights for €9.2 million ($10.2 million), increasing the Company’s ownership to 99.4%. On October 10, 2023, the Company acquired the remaining 0.6% of the outstanding shares in Nordic Lights for €0.8 million ($0.9 million), as determined by the Finnish arbitral tribunal administering the redemption proceedings for the shares not tendered to the Company. Accordingly, the Company owned 100% of the outstanding shares in Nordic Lights as of October 10, 2023. The acquisition of Nordic Lights complements the Company’s existing LED lighting solution offerings.

10

The acquisition was funded through a combination of borrowings under the Company's revolving credit facility and cash on hand. The results of the operations of Nordic Lights are reported within the Industrial segment from the date of acquisition. The acquisition was accounted for as a business combination. The Company has estimated the preliminary fair value of net assets acquired based on information currently available and will continue to adjust those estimates as additional information becomes available, including the refinement of valuation assumptions. As the Company finalizes the fair value of assets acquired and liabilities assumed, additional purchase price allocation adjustments will be recorded during the measurement period, but no later than one year from the date of the acquisition. The Company will reflect measurement period adjustments in the period in which the adjustments are determined. Measurement period adjustments recognized in the three months ended October 28, 2023, resulted from the receipt of incremental data utilized in the determination of fair value, including valuation assumptions.

The preliminary fair value and subsequent measurement period adjustments of the assets acquired and liabilities assumed, including a reconciliation to the total purchase price, were as follows:

	As reported as of July 29, 2023			Measurement period adjustments			As of October 28, 2023
(in millions)
Cash and cash equivalents	$	19.6		$	—		$	19.6
Accounts receivable		17.1			—			17.1
Inventories		9.6			(0.2	)		9.4
Property, plant and equipment		12.9			3.4			16.3
Identifiable intangible assets		68.1			24.5			92.6
Accounts payable		(10.8	)		—			(10.8	)
Long-term debt		(24.4	)		—			(24.4	)
Other assets and liabilities, net		(2.8	)		(0.5	)		(3.3	)
Deferred tax liabilities		(13.4	)		(5.4	)		(18.8	)
Total identifiable net assets acquired		75.9			21.8			97.7
Goodwill		69.6			(21.8	)		47.8
Total fair value of net assets acquired		145.5			—			145.5
Less: redeemable noncontrolling interest		(11.3	)		—			(11.3	)
Total purchase price	$	134.2		$	—		$	134.2

The noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the fair value of net assets acquired, as of the acquisition date. The noncontrolling interest is classified as a redeemable noncontrolling interest on the condensed consolidated balance sheets as minority shareholders owning less than 10% of the outstanding shares in a company in Finland have the right to require the company to redeem their shares. As noted above, in the six months ended October 28, 2023, the Company acquired the entire redeemable noncontrolling interest.

Goodwill arising from the acquisition was included in the Industrial segment as of October 28, 2023 and was attributable to potential synergies and an assembled workforce. The Company does not expect any recognized goodwill from this acquisition to be deductible for income tax purposes.

Intangible assets primarily include customer relationships, technology licenses and trademarks. The weighted average amortization period for the acquired intangible assets is approximately 18.2 years.

The pro-forma effects of this acquisition would not materially impact the Company’s operating results for the six months ended October 29, 2022, and as a result no pro-forma financial statements are presented. In the six months ended October 28, 2023, additional acquisition costs of $0.5 million were incurred and reported in selling and administrative expenses.

Disposition

In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of the Dabir business in the Medical segment. On October 13, 2023, the Company sold certain assets and contracts of its Dabir business to a third party for consideration of $1.5 million. In the three and six months ended October 28, 2023, the Company recorded a loss on the sale, including transaction costs, of $0.6 million, which was included in other income, net on the Company's condensed consolidated statement of operations. The discontinuation of the Dabir business does not qualify as a discontinued operation as it does not represent a strategic shift that would have a major effect on the Company's operations or financial results.

11

Note 4. Income Taxes

The provision for income taxes for an interim period is based on an estimated annual effective income tax rate applied to ordinary year-to-date earnings or losses. The estimated annual effective income tax rate is determined excluding the effects of unusual or significant one-time items that are reported net of the related tax effects in the period in which they occur. In addition, any material effects of enacted tax law or rate changes as well as the Company’s ability to utilize various tax assets is recognized in the period in which the change occurs.

The computation of the estimated annual effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year by jurisdiction, certain book to tax adjustments, and the likelihood of the realizability of deferred tax assets generated in the current year. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as the Company’s tax environment changes.

The Company’s income tax (benefit) expense and effective tax rate for the three and six months ended October 28, 2023 and October 29, 2022 were as follows:

	Three Months Ended						Six Months Ended
($ in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Pre-tax (loss) income	$	(55.5	)	$	33.4		$	(54.5	)	$	59.3
Income tax (benefit) expense	$	(0.2	)		5.8		$	(0.1	)		10.2
Effective tax rate		0.4	%		17.4	%		0.2	%		17.2	%

The effective tax rate for the three and six months ended October 28, 2023 was lower than the U.S. federal statutory tax rate of 21% primarily due to the impact of an impairment of goodwill which is non-deductible for tax purposes, income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, offset by global intangible low-tax income. The effective tax rate for the three and six months ended October 29, 2022 was lower than the U.S. federal statutory tax rate of 21% primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses.

The Company’s gross unrecognized income tax benefits were $4.6 million and $4.5 million as of October 28, 2023 and April 29, 2023, respectively. If any portion of the Company’s unrecognized tax benefits is recognized, it would impact the Company’s effective tax rate. The unrecognized tax benefits are reviewed periodically and adjusted for changing facts and circumstances, such as tax audits, the lapsing of applicable statutes of limitations and changes in tax law. The Company recognizes interest and penalties related to income tax uncertainties in income tax expense. Accrued interest and penalties were $0.3 million and $0.2 million as of October 28, 2023 and April 29, 2023, respectively.

Note 5. Balance Sheet Components

Cash and cash equivalents

Cash and cash equivalents consist of cash and highly liquid investments with maturities of three months or less. Highly liquid investments include money market funds which are classified within Level 1 of the fair value hierarchy. As of October 28, 2023 and April 29, 2023, the Company had a balance of $0.2 million and $1.3 million, respectively, in money market accounts.

Accounts receivable and allowance for doubtful accounts

Accounts receivable are customer obligations due under normal trade terms and are presented net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on the current expected credit loss impairment model. The Company applies a historical loss rate based on historic write-offs to aging categories. The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. The Company may also record a specific reserve for individual accounts when it becomes aware of specific customer circumstances, such as in the case of a bankruptcy filing or deterioration in the customer’s operating results or financial position. The allowance for doubtful accounts balance was $1.5 million and $1.3 million at October 28, 2023 and April 29, 2023, respectively.

12

Inventories

Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand. A summary of inventories is shown below:

(in millions)	October 28, 2023		April 29, 2023
Finished products	$	47.3	$	36.6
Work in process		17.7		14.4
Raw materials		118.9		108.7
Total inventories	$	183.9	$	159.7

Property, plant and equipment

Property, plant and equipment is stated at cost. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method using estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment. A summary of property, plant and equipment is shown below:

(in millions)	October 28, 2023			April 29, 2023
Land	$	3.0		$	3.0
Buildings and building improvements		99.5			98.8
Machinery and equipment		411.4			414.3
Construction in progress		48.0			40.6
Total property, plant and equipment, gross		561.9			556.7
Less: accumulated depreciation		(337.3	)		(336.4	)
Property, plant and equipment, net	$	224.6		$	220.3

Depreciation expense was $8.2 million and $7.5 million in the three months ended October 28, 2023 and October 29, 2022, respectively. Depreciation expense was $16.5 million and $15.1 million in the six months ended October 28, 2023 and October 29, 2022, respectively. As of October 28, 2023 and April 29, 2023, capital expenditures recorded in accounts payable totaled $5.6 million and $4.5 million, respectively.

Pre-production tooling costs related to long-term supply arrangements

The Company incurs pre-production tooling costs related to products produced for its customers under long-term supply arrangements. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred, unless the costs are reimbursable by the customer. As of October 28, 2023 and April 29, 2023, the Company had $44.5 million and $36.1 million, respectively, of pre-production tooling costs related to customer-owned tools for which reimbursement is contractually guaranteed by the customer or for which the customer has provided a non-cancelable right to use the tooling.

Costs for molds, dies and other tools used in products produced for its customers under long-term supply arrangements for which the Company has title are capitalized in property, plant and equipment and amortized over the shorter of the life of the arrangement or the estimated useful life of the assets. As of October 28, 2023 and April 29, 2023, Company-owned tooling was $15.6 million and $12.2 million, respectively.

Note 6. Goodwill and Other Intangible Assets

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. A summary of the changes in the carrying amount of goodwill, by segment, is shown below:

(in millions)	Automotive			Industrial			Total
Balance as of April 29, 2023	$	106.2		$	195.7		$	301.9
Acquisition (Note 3)		—			(21.8	)		(21.8	)
Impairment		(56.5	)		—			(56.5	)
Foreign currency translation		(0.3	)		(2.6	)		(2.9	)
Balance as of October 28, 2023	$	49.4		$	171.3		$	220.7

13

The Company tests goodwill and indefinite-lived intangible assets for impairment on an annual basis as of the beginning of the fourth quarter each fiscal year. In addition, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore require interim goodwill impairment testing, including long-term revenue growth projections, profitability, discount rates, volatility in the Company's market capitalization, and general industry, market and macroeconomic conditions.

As a result of sustained decreases in the Company’s publicly quoted share price, market capitalization and lower than expected operating results, the Company concluded that a triggering event had occurred requiring an interim goodwill impairment assessment. These factors suggested that the fair value of one or more of the Company's reporting units may have fallen below their carrying amounts. The Company quantitatively assessed its reporting units which have performed substantially below the forecast used in its last quantitative fair value test. The reporting units that were quantitatively assessed were North American Automotive ("NAA") and European Automotive ("EA").

The Company engaged a third-party valuation specialist to assist management in performing the interim goodwill impairment assessment. The fair value of the NAA and EA reporting units were estimated using a combination of the income approach and market approach, weighted accordingly for the specific circumstances of the reporting unit. The income approach uses a discounted cash flow method and the market approach uses appropriate valuation multiples observed for the reporting unit’s guideline public companies. The determination of discounted cash flows are based on management’s estimates of revenue growth rates and earnings before interest, taxes, depreciation and amortization (“EBITDA”) margins, taking into consideration business and market conditions for the countries and markets in which the reporting unit operates. The Company calculates the discount rate based on a market-participant, risk-adjusted weighted average cost of capital, which considers industry specific rates of return on debt and equity capital for a target industry capital structure, adjusted for risks associated with business size, geography and other factors specific to the reporting unit. Long-range forecasting involves uncertainty which increases with each successive period. Revenue growth rates and profitability assumptions, especially in the outer years, involve a greater degree of uncertainty.

Based upon the results of the quantitative impairment test, the Company determined the carrying value of the NAA and EA reporting units exceeded their fair value at October 28, 2023. As a result, the Company recognized a non-cash goodwill impairment charge of $56.5 million ($50.4 million for NAA and $6.1 million for EA, respectively) in the three and six months ended October 28, 2023, which was determined as the excess carrying value over fair value of the respective reporting unit up to the carrying value of the goodwill immediately prior to the impairment. Any significant changes to the assumptions regarding future performance, an adverse change to macroeconomic conditions, a further reduction in the Company's market capitalization, or a change to other assumptions could result in impairment losses in the future, which could be significant.

A summary of goodwill by reporting unit is as follows:

(in millions)	October 28, 2023		April 29, 2023
Grakon Industrial	$	123.9	$	124.5
North American Automotive		49.4		99.8
Nordic Lights		45.8		69.6
European Automotive		—		6.4
Other		1.6		1.6
Total	$	220.7	$	301.9

Other intangible assets, net

Details of identifiable intangible assets are shown below:

	As of October 28, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	303.6	$	(76.1	)	$	227.5		15.2
Trade names, patents and technology licenses		74.0		(38.6	)		35.4		7.1
Total amortized intangible assets		377.6		(114.7	)		262.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	379.4	$	(114.7	)	$	264.7

14

	As of April 29, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	286.7	$	(68.2	)	$	218.5		14.8
Trade names, patents and technology licenses		71.6		(35.2	)		36.4		6.0
Total amortized intangible assets		358.3		(103.4	)		254.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	360.1	$	(103.4	)	$	256.7

Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:

(in millions)
Fiscal Year:
Remainder of 2024	$	11.8
2025		23.1
2026		22.2
2027		21.6
2028		19.3
Thereafter		164.9
Total	$	262.9

Note 7. Derivative Instruments and Hedging Activities

The Company is exposed to various market risks including, but not limited to, foreign currency exchange rates and market interest rates. The Company strives to control its exposure to these risks through our normal operating activities and, where appropriate, through the use of derivative financial instruments. Derivative financial instruments are measured at fair value on a recurring basis.

For a designated cash flow hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded in accumulated other comprehensive income (“AOCI”) in the condensed consolidated balance sheets. When the underlying hedged transaction is realized, the gain or loss previously included in AOCI is recorded in earnings and reflected in the condensed consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. The gain or loss associated with changes in the fair value of derivatives not designated as hedges are recorded immediately in the condensed consolidated statements of income on the same line as the associated risk. For a designated net investment hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded as a cumulative translation adjustment in AOCI in the condensed consolidated balance sheets.

Net investment hedges

The Company is exposed to the risk that adverse changes in foreign currency exchange rates could impact its net investment in non-U.S. subsidiaries. To manage this risk, the Company designates certain qualifying derivative and non-derivative instruments, including cross-currency swaps and foreign currency-denominated debt, as net investment hedges of certain non-U.S. subsidiaries.

The Company had a variable-rate, cross-currency swap, with a notional value of $60.0 million (€54.8 million), that matured on August 31, 2023 with a gain of approximately $0.6 million. The cross-currency swap was designated as a hedge of the Company’s net investment in its euro-denominated subsidiaries. The gain will remain in AOCI until the hedged net investment is sold or substantially liquidated.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter, under the spot-to-spot method. The Company recognizes the impact of all other changes in fair value of the derivative, which represents the interest rate differential of the cross-currency swap, through interest expense. For the three months ended October 28, 2023 and October 29, 2022, the Company recorded gains of $0.4 million and $0.6 million, respectively, in interest expense, net in the condensed consolidated statements of income. For the six months ended October 28, 2023 and October 29, 2022, the Company recorded gains of $1.1 million and $0.9 million, respectively, in interest expense, net in the condensed consolidated statements of income.

15

The Company has also designated its euro-denominated long-term borrowings of $290.6 million under the Credit Agreement as a hedge of the Company's investment in its euro-denominated subsidiaries. The objective of the designation is to protect the net investment in the foreign operation against adverse changes in the euro exchange rate. The change in the value of the euro-denominated long-term borrowings, which is due to changes in foreign exchange rates, is recorded as a cumulative translation adjustment in AOCI, net of tax. For the three months ended October 28, 2023, the transaction gain associated with this net investment hedge reported in AOCI was $7.5 million. For the six months ended October 28, 2023 the transaction gain associated with this net investment hedge reported in AOCI was $7.3 million.

Interest rate swaps

The Company utilizes interest rate swaps to limit its exposure to market fluctuations on its variable-rate borrowings. The interest rate swaps effectively convert a portion of the Company's variable rate borrowings to a fixed rate based upon a determined notional amount. The Company has an interest rate swap, maturing on October 31, 2027, with a notional value of $145.5 million (€132.0 million) and had two interest rate swaps that matured on August 31, 2023, with a notional value of $100.0 million. The interest rate swaps are designated as cash flow hedges.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter. The effective portion of the periodic changes in fair value is recognized in AOCI in the condensed consolidated balance sheets. Subsequently, the accumulated gains and losses recorded in AOCI are reclassified to income in the period during which the hedged cash flow impacts earnings, which are expected to be immaterial over the next 12 months. No ineffectiveness was recognized in the three or six months ended October 28, 2023 and October 29, 2022.

Derivatives not designated as hedges

The Company uses short-term foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. These forward contracts are not designated as hedging instruments. Gains and losses on these forward contracts are recognized in other income, net, along with the foreign currency gains and losses on monetary assets and liabilities, in the condensed consolidated statements of income.

As of October 28, 2023 and April 29, 2023, the Company held foreign currency forward contracts with a notional value of $71.9 million and $59.9 million, respectively. During the three and six months ended October 28, 2023, the Company recognized a loss of $0.8 million and $2.7 million, respectively, related to foreign currency forward contracts in the condensed consolidated statements of income. During the three and six months ended October 29, 2022, the Company recognized a loss of $2.4 million and $2.8 million, respectively, related to foreign currency forward contracts in the condensed consolidated statements of income.

Fair value of derivative instruments on the balance sheet

The fair value of derivative instruments are classified as Level 2 within the fair value hierarchy and are recorded in the balance sheets as follows:

		Asset/(Liability)
(in millions)	Financial Statement Caption	October 28, 2023			April 29, 2023
Derivatives designated as hedging instruments:
Net investment hedges	Other accrued liabilities	$	—		$	(0.5	)
Interest rate swaps	Prepaid expenses and other current assets	$	—		$	1.6
Interest rate swaps	Other long-term liabilities	$	(1.1	)	$	—
Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	—		$	0.1
Foreign currency forward contracts	Other accrued liabilities	$	(0.1	)	$	(0.1	)

Effect of derivative instruments on comprehensive income (loss)

Gross amounts recorded in other comprehensive income (loss) were as follows:

	Three Months Ended					Six Months Ended
(in millions)	October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Net investment hedges	$	1.1		$	1.4	$	1.2		$	3.4
Interest rate swaps		(0.4	)		0.7		(2.7	)		0.7
Total	$	0.7		$	2.1	$	(1.5	)	$	4.1

16

Note 8. Debt

A summary of debt is shown below:

(in millions)	October 28, 2023			April 29, 2023
Revolving credit facility	$	330.6		$	305.4
Other debt		4.4			4.7
Unamortized debt issuance costs		(3.0	)		(3.3	)
Total debt		332.0			306.8
Less: current maturities		(3.0	)		(3.2	)
Total long-term debt	$	329.0		$	303.6

Revolving credit facility/term loan

On October 31, 2022, the Company entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amends and restates the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750,000,000, (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement. In addition, the Credit Agreement permits the Company to increase the revolving commitments and/or add one or more tranches of term loans under the Credit Agreement from time to time by up to an amount equal to (i) $250,000,000 plus (ii) an additional amount so long as the leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Credit Agreement matures on October 31, 2027.

Loans denominated in US dollars under the Credit Agreement bear interest at either (a) an adjusted base rate or (b) an adjusted term Secured Overnight Financing Rate (“SOFR”) rate or term SOFR daily floating rate (in each case, as determined in accordance with the provisions of the Credit Agreement) in each case plus an applicable rate (the “Applicable Rate”) ranging between 0.375% and 1.25%, in the case of adjusted base rate loans, and between 1.375% and 2.25%, in the case of adjusted term SOFR rate loans and term SOFR daily floating rate loans. Loans denominated in euros will bear interest at the Euro Interbank Offered Rate plus an Applicable Rate ranging between 1.375% and 2.25%. The Applicable Rate is set based on the Company’s consolidated leverage ratio.

As of October 28, 2023, the outstanding balance under the revolving credit facility included $290.6 million (€275.0 million) of euro-denominated borrowings. The Company has designated the euro-denominated borrowings as a net investment hedge of the foreign currency exposure of its investments in euro-denominated subsidiaries. Refer to Note 7, "Derivative Financial Instruments and Hedging Activities" for further information.

The weighted-average interest rate on outstanding US dollar and euro-denominated borrowings under the Credit Agreement was approximately 7.2% and 5.6%, respectively, as of October 28, 2023. The Credit Agreement contains customary representations and warranties, financial covenants, restrictive covenants and events of default. As of October 28, 2023, the Company was in compliance with all the covenants in the Credit Agreement.

Other debt

One of the Company’s European subsidiaries has debt that consists of three notes with maturities ranging from 2023 to 2031. The weighted-average interest rate on this debt was approximately 1.4% at October 28, 2023 and $3.0 million of the debt was classified as short-term.

Note 9. Shareholders’ Equity

Share buyback program

The Board of Directors authorized a program to purchase up to $200.0 million of the Company’s outstanding common stock through June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

17

The following table summarizes the Company’s stock buyback activity under this share buyback program:

	Three Months Ended				Six Months Ended
(in millions, except share and per share data)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Shares purchased		322,779		508,179		322,779		825,814
Average price per share	$	24.03	$	38.69	$	24.03	$	38.21
Total cost	$	7.8	$	19.7	$	7.8	31.6

As of October 28, 2023, a total of 3,113,154 shares have been purchased at a total cost of $127.1 million since the commencement of the share buyback program. All purchased shares were retired and are reflected as a reduction of common stock for the par value of shares, with the excess applied as a reduction to retained earnings. As of October 28, 2023, the dollar value of shares that remained available to be purchased by the Company under this share buyback program was $72.9 million.

Dividends

The Company paid dividends totaling $4.8 million and $4.9 million in the three months ended October 28, 2023 and October 29, 2022, respectively. The Company paid dividends totaling $10.1 million and $9.9 million in the six months ended October 28, 2023 and October 29, 2022, respectively. Dividends paid in the six months ended October 28, 2023 include $0.4 million of dividend equivalent payments for restricted stock units that vested at the end of fiscal 2023.

Accumulated other comprehensive income (loss)

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in AOCI, net of tax is shown below:

	Three Months Ended October 28, 2023									Six Months Ended October 28, 2023
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(22.3	)	$	(0.8	)	$	(23.1	)	$	(19.8	)	$	0.8		$	(19.0	)
Other comprehensive income (loss)		(17.6	)		0.7			(16.9	)		(20.3	)		(1.5	)		(21.8	)
Tax (expense) benefit		(2.6	)		(0.3	)		(2.9	)		(2.4	)		0.3			(2.1	)
Net other comprehensive income (loss)		(20.2	)		0.4			(19.8	)		(22.7	)		(1.2	)		(23.9	)
Balance at the end of period	$	(42.5	)	$	(0.4	)	$	(42.9	)	$	(42.5	)	$	(0.4	)	$	(42.9	)

	Three Months Ended October 29, 2022									Six Months Ended October 29, 2022
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(41.4	)	$	5.2		$	(36.2	)	$	(30.5	)	$	3.7		$	(26.8	)
Other comprehensive income (loss)		(19.9	)		2.1			(17.8	)		(30.8	)		4.1			(26.7	)
Tax (expense) benefit		0.2			(0.5	)		(0.3	)		0.2			(1.0	)		(0.8	)
Net other comprehensive income (loss)		(19.7	)		1.6			(18.1	)		(30.6	)		3.1			(27.5	)
Balance at the end of period	$	(61.1	)	$	6.8		$	(54.3	)	$	(61.1	)	$	6.8		$	(54.3	)

Stock-based compensation

The Company has granted stock options, restricted stock awards (“RSAs”), performance units (“PUs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under the Methode Electronics, Inc. 2022 Omnibus Incentive Plan (“2022 Plan”), the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”), the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company’s stockholders approved the 2022 Plan on September 14, 2022. The Company can no longer make grants under the 2014 Plan, 2010 Plan and 2004 Plan.

Subject to adjustment as provided in the 2022 Plan and the 2022 Plan’s share counting provisions, the number of shares of the Company's common stock that will be available for all awards under the 2022 Plan is 5,550,000, less one share for every one share of common stock subject to an option or SAR award granted after April 30, 2022 under the 2014 Plan and 2.28 shares for every one share that was subject to an award other than an option or SAR granted after April 30, 2022 under the 2014 Plan. As of October 28, 2023, there were 4,943,780 shares available for award under the 2022 Plan.

18

Restricted stock awards and performance units

As of October 28, 2023, the Company had 933,674 RSAs outstanding which may be earned based on the achievement of an earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) measure for fiscal 2025. The RSAs will vest ranging from 0% (for performance below threshold) to 100% (target performance) based on the achievement of the EBITDA performance measure and continued employment. In addition, if the target performance is exceeded, up to an additional 466,837 PUs can be earned that will be settled in cash. At the discretion of the Compensation Committee, the PUs may be settled in shares of common stock.

The fair value of the RSAs was based on the closing stock price on the date of grant and the RSAs earn dividend equivalents during the vesting period, which are forfeitable if the RSAs do not vest. Compensation expense for the RSAs is recognized when it is probable the minimum threshold performance criteria will be achieved. Compensation expense for the PUs is recognized when it is probable that the target performance criteria will be exceeded. The Company assesses the probability of vesting at each balance sheet date and adjusts compensation costs based on the probability assessment. The cash-settled PUs represent a non-equity unit with a conversion value equal to the fair market value of a share of the Company’s common stock on the vesting date. The PUs are classified as liability awards due to the cash settlement feature and are re-measured at each balance sheet date. In accordance with ASC 718, based on projections of the Company’s current business portfolio, no compensation expense has been recognized for the RSAs or PUs to date, as the performance conditions are not probable of being met. Unrecognized stock-based compensation expense at target level of performance is $26.8 million as of October 28, 2023, which, subject to the performance conditions being met, will be recognized through fiscal 2025. The following table summarizes RSA activity:

	Restricted stock awards		Weighted average grant date fair value
Non-vested at April 29, 2023		933,674	$	28.73
Awarded		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Non-vested at October 28, 2023		933,674	$	28.73

Restricted stock units

RSUs granted vest over a pre-determined period of time, up to five years from the date of grant. The fair value of the RSUs granted are based on the closing stock price on the date of grant and earn dividend equivalents during the vesting periods, which are forfeitable if the RSUs don’t vest. The following table summarizes RSU activity:

	Restricted stock units			Weighted average grant date fair value
Non-vested at April 29, 2023		727,467		$	30.60
Awarded		207,050		$	22.83
Vested		(866	)	$	38.24
Forfeited		(13,474	)	$	41.62
Non-vested at October 28, 2023		920,177		$	28.68

Under the various stock plans, common stock underlying vested RSUs held by certain executives will not be delivered until termination of employment or a change of control of the Company. As of October 28, 2023, common stock to be delivered to these executives totaled 577,055 shares.

19

Director awards

The Company grants stock awards to its non-employee directors as a component of their compensation. The stock awards vest immediately upon grant. Non-employee directors may elect to defer receipt of their shares under the Company’s non-qualified deferred compensation plan. The following table summarizes awards granted to non-employee directors:

	Non-employee director awards			Deferred non-employee director awards		Total			Weighted average grant date fair value
Outstanding at April 29, 2023		—			45,750		45,750		$	40.56
Awarded		16,804			30,194		46,998		$	33.22
Issued		(16,804	)		—		(16,804	)	$	33.32
Outstanding at October 28, 2023		—			75,944		75,944		$	37.62

Stock options

The following table summarizes stock option activity:

	Stock options		Weighted average exercise price		Weighted- average life (years)		Aggregate intrinsic value (in millions)
Outstanding and exercisable at April 29, 2023		20,000	$	37.01		1.2	$	0.1
Exercised		—	$	—
Forfeited		—	$	—
Outstanding and exercisable at October 28, 2023		20,000	$	37.01		0.7	$	0.0

The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on that date.

Stock-based compensation expense

All stock-based awards to employees and non-employee directors are recognized in selling and administrative expenses on the condensed consolidated statements of income. Awards subject to graded vesting are recognized using the accelerated recognition method over the requisite service period. The table below summarizes the stock-based compensation expense related to the equity awards:

	Three Months Ended				Six Months Ended
(in millions)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
RSUs	$	1.3	$	2.7	$	2.3	$	5.1
Deferred non-employee director awards		—		—		1.0		1.0
Non-employee director awards		—		—		0.6		0.6
Total stock-based compensation expense	$	1.3	$	2.7	$	3.9	$	6.7

Note 10. (Loss) Income per Share

Basic (loss) income per share attributable to Methode is calculated by dividing net (loss) income attributable to Methode by the weighted average number of common shares outstanding for the applicable period, but excludes any contingently issued shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted (loss) income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.

20

The following table sets forth the computation of basic and diluted (loss) income per share attributable to Methode:

	Three Months Ended					Six Months Ended
	October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Numerator:
Net (loss) income attributable to Methode (in millions)	$	(55.3	)	$	27.6	$	(54.4	)	$	49.1
Denominator:
Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units		35,671,677			36,126,132		35,679,776			36,346,054
Dilutive potential common shares		—			715,699		—			682,762
Denominator for diluted income per share		35,671,677			36,841,831		35,679,776			37,028,816
(Loss) income per share attributable to Methode:
Basic	$	(1.55	)	$	0.76	$	(1.52	)	$	1.35
Diluted	$	(1.55	)	$	0.75	$	(1.52	)	$	1.33
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding		1,543,183			940,510		1,536,206			934,522

In the three and six months ended October 28, 2023, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 584,000 and 589,000 common shares for the three and six months ended October 28, 2023, respectively.

Note 11. Segment Information

An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenues and incur expenses, and about which separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. The CODM is the Company’s President and Chief Executive Officer. The Company has four reporting segments as described below.

The Automotive segment supplies electronic and electro-mechanical devices and related products to automobile OEMs, either directly or through their tiered suppliers. Products include integrated center consoles, hidden switches, ergonomic switches, transmission lead-frames, LED-based lighting and sensors, which incorporate magneto-elastic sensing and other technologies that monitor the operation or status of a component or system.

The Industrial segment manufactures external lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices, custom power-product assemblies, such as our PowerRail® solution, high-current low-voltage flexible power cabling systems and powder-coated busbars that are used in various markets and applications, including aerospace, computers, industrial, power conversion, military, telecommunications and transportation.

The Interface segment provides a variety of copper and fiber-optic interface and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale and telecommunications markets. Solutions include copper transceivers and solid-state field-effect consumer touch panels.

The Medical segment is made up of the Company’s medical device business, Dabir Surfaces, with its surface support technology aimed at pressure injury prevention. Methode developed the technology for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures. In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of Dabir Surfaces. In October 2023, the Company sold certain assets of its Dabir Surfaces business. See Note 3, "Acquisition and Disposition" for more information.

21

The tables below present information about the Company’s reportable segments:

	Three Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations/ Corporate			Consolidated
Net sales	$	158.0		$	128.0		$	11.7	$	1.6		$	(11.3	)	$	288.0
Transfers between segments		(3.7	)		(7.6	)		—		—			11.3			—
Net sales to unaffiliated customers	$	154.3		$	120.4		$	11.7	$	1.6		$	—		$	288.0
Income (loss) from operations	$	(61.5	)	$	25.7		$	1.0	$	(0.7	)	$	(15.8	)	$	(51.3	)
Interest expense, net																4.4
Other income, net																(0.2	)
Pre-tax loss															$	(55.5	)
Goodwill impairment	$	56.5		$	—		$	—	$	—		$	—		$	56.5

	Three Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	198.3		$	107.8		$	14.1	$	1.1		$	(5.4	)	$	315.9
Transfers between segments		(1.4	)		(4.0	)		—		—			5.4			—
Net sales to unaffiliated customers	$	196.9		$	103.8		$	14.1	$	1.1		$	—		$	315.9
Income (loss) from operations	$	23.4		$	25.0		$	1.6	$	(1.4	)	$	(15.8	)	$	32.8
Interest expense, net																0.5
Other income, net																(1.1	)
Pre-tax income															$	33.4

	Six Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface			Medical			Eliminations/ Corporate			Consolidated
Net sales	$	319.1		$	250.6		$	27.0		$	2.4		$	(21.4	)	$	577.7
Transfers between segments		(6.5	)		(14.8	)		(0.1	)		—			21.4			—
Net sales to unaffiliated customers	$	312.6		$	235.8		$	26.9		$	2.4		$	—		$	577.7
Income (loss) from operations	$	(64.3	)	$	49.9		$	3.9		$	(2.9	)	$	(34.1	)	$	(47.5	)
Interest expense, net																	7.2
Other income, net																	(0.2	)
Pre-tax loss																$	(54.5	)
Goodwill impairment	$	56.5		$	—		$	—		$	—		$	—		$	56.5

	Six Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	375.6		$	201.5		$	27.1	$	1.8		$	(7.7	)	$	598.3
Transfers between segments		(2.1	)		(5.6	)		—		—			7.7			—
Net sales to unaffiliated customers	$	373.5		$	195.9		$	27.1	$	1.8		$	—		$	598.3
Income (loss) from operations	$	38.1		$	47.4		$	3.2	$	(2.9	)	$	(31.2	)	$	54.6
Interest expense, net																0.5
Other income, net																(5.2	)
Pre-tax income															$	59.3

22

(in millions)	October 28, 2023		April 29, 2023
Identifiable assets:
Automotive	$	643.3	$	700.2
Industrial		636.8		672.3
Interface		117.5		127.2
Medical		0.8		6.2
Eliminations/Corporate		86.5		73.2
Total identifiable assets	$	1,484.9	$	1,579.1

Note 12. Contingencies

Certain litigation arising in the normal course of business is pending against us. The Company is, from time-to-time, subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, employment-related matters, environmental matters and intellectual property matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the Company's opinion, based on the information available, that it has adequate reserves for these liabilities.

Hetronic Germany-GmbH Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. The Company became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, the Company terminated all of its agreements with the Fuchs companies. On June 20, 2014, the Company filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, the Company amended its complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties have filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. The Company opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court heard arguments in this matter on March 21, 2023. On June 29, 2023, the Supreme Court vacated the Tenth Circuit’s August 2021 decision and remanded the matter back to the Tenth Circuit for further proceedings. On September 1, 2023, the Tenth Circuit requested supplemental briefing from the parties regarding the effect of the Supreme Court’s decision on the appeal and the proper course of further proceedings. That briefing was thereafter submitted.

Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that the Company will be able to collect all or any portion of the judgment. Furthermore, defendants Abitron Germany and Hetronic Germany filed for insolvency in German court in September and October 2023 respectively, and the Germany insolvency court then appointed a receiver. These insolvency proceedings could potentially adversely impact our ability to enforce or collect upon the judgment or portions of the judgment or otherwise pursue or enforce claims or rights against those defendants.

23

Note 13. Restructuring

The Company continually monitors market factors and industry trends and takes restructuring actions to reduce overall costs and improve operational profitability as appropriate. Restructuring actions generally result in charges for employee termination benefits, plant closures, asset impairments and contract termination costs.

As noted above, the Company made the decision to initiate the discontinuation of the Dabir business in the Medical segment. The Company recognized $0.4 million and $0.5 million of severance costs in the three and six months ended October 28, 2023, respectively, in selling and administrative expenses. In addition, in the six months ended October 28, 2023, the Company recognized fixed asset impairment charges of $0.6 million in cost of products sold related to this restructuring action. In the Automotive segment, the Company recognized $0.2 million of severance costs in the three and six months ended October 28, 2023. In the three and six months ended October 29, 2022, restructuring costs primarily related to an impairment of an operating lease right-of-use asset.

Employee termination benefits are accrued upon the commitment to a termination plan and when the benefit arrangement is communicated to affected employees, or when liabilities are determined to be probable and estimable. Asset impairment charges relate to the impairment of right-of-use lease assets and equipment. Components of restructuring costs were as follows:

	Three Months Ended				Six Months Ended
(in millions)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Automotive	$	0.2	$	—	$	0.2	$	—
Industrial		—		0.4		—		0.5
Interface		—		—		—		—
Medical		0.4		—		1.1		—
Eliminations/Corporate		—		0.1		—		0.1
Total restructuring costs	$	0.6	$	0.5	$	1.3	$	0.6
Recognized in:
Cost of products sold	$	0.2	$	0.1	$	0.8	$	0.1
Selling and administrative expenses		0.4		0.4		0.5		0.5
	$	0.6	$	0.5	$	1.3	$	0.6

The Company's restructuring liability was $0.1 million as of October 28, 2023. Estimates of restructuring costs are based on information available at the time such charges are recorded. Due to the inherent uncertainty involved in estimating restructuring costs, actual amounts paid for such activities may differ from amounts initially recorded. Accordingly, the Company may record revisions of previous estimates by adjusting previously established accruals.

Note 14. Subsequent Events

On December 5, 2023, the Board of Directors of the Company removed Joseph Khoury from his position as Chief Operating Officer of the Company, and Mr. Khoury was terminated as an employee of the Company’s Egyptian subsidiary and is no longer associated with the Company. Mr. Khoury was placed on leave from that position on July 10, 2023, as previously reported in the Company’s Current Report on Form 8-K filed on July 14, 2023. As previously disclosed, multiple other officers of the Company have assumed Mr. Khoury’s management duties during this period, while remaining in their current positions and as a result, the Company has eliminated the position of Chief Operating Officer for the present time following Mr. Khoury’s departure from Methode. As a result, the Company expects to reverse between $3.5 million and $3.9 million of previously recognized compensation expense in the third quarter of fiscal 2024.

On December 6, 2023, the Board of Directors of the Company declared a quarterly dividend of $0.14 per share to be paid on January 26, 2024, to common stockholders of record at the close of business on January 12, 2024.

24

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

As used herein, “we,” “us,” “our,” the “Company” or “Methode” means Methode Electronics, Inc. and its subsidiaries.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (“Quarterly Report”) includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect, when made, our current views with respect to current events and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to our operations and business environment, which may cause our actual results to be materially different from any future results, express or implied, by such forward-looking statements. All statements that address future operating, financial or business performance or our strategies or expectations are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “outlook” or “continue,” and other comparable terminology. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following:

•Dependence on our supply chain, including semiconductor suppliers;

•Impact from pandemics, such as the COVID-19 pandemic;

•Dependence on the automotive and commercial vehicle industries;

•Impact from inflation;

•Dependence on a small number of large customers, including one large automotive customer;

•Risks relating to our use of requirements contracts;

•Failure to attract and retain qualified personnel;

•Risks related to conducting global operations;

•Potential work stoppages;

•Dependence on the availability and price of materials;

•Timing, quality and cost of new program launches;

•Ability to compete effectively;

•Ability to withstand pricing pressures, including price reductions;

•Our lengthy sales cycle;

•Ability to successfully benefit from acquisitions and divestitures;

•Impact from production delays or cancelled orders;

•Investment in programs prior to the recognition of revenue;

•Electric vehicle ("EV") adoption rates;

•Ability to withstand business interruptions;

•Breaches to our information technology systems or service interruptions;

•Ability to keep pace with rapid technological changes;

•Ability to protect our intellectual property;

•Costs associated with environmental, health and safety regulations;

•International trade disputes resulting in tariffs and our ability to mitigate tariffs;

•Impact from climate change and related regulations;

•Ability to avoid design or manufacturing defects;

•Ability to remediate a material weakness in our internal control over financial reporting;

•Recognition of goodwill and other intangible asset impairment charges;

•Ability to manage our debt levels and any restrictions thereunder;

•Interest rate changes and variable rate instruments;

•Currency fluctuations;

•Adjustments to compensation expense for performance-based awards;

•Timing and magnitude of costs associated with restructuring activities;

•Income tax rate fluctuations; and

•Judgments related to accounting for tax positions.

25

Additional details and factors are discussed under the caption “Risk Factors” in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended April 29, 2023. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. Any forward-looking statements made by us speak only as of the date on which they are made. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, subsequent events or otherwise.

Overview

We are a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. We design, engineer and produce mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing our broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

Our solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment and consumer appliance. Our business is managed on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.

In the first quarter of fiscal 2024, we made the decision to initiate the discontinuation of the Dabir business in the Medical segment. In October 2023, we sold certain assets of the Dabir business, and no longer operate this business. For further information, see Note 3, “Acquisition and Disposition” to the condensed consolidated financial statements included in this Report.

Impacts of Macroeconomic and Geopolitical Conditions

Adverse macroeconomic conditions, including but not limited to inflation, slower growth or recession, changes to fiscal and monetary policy, higher interest rates, wage and commodity inflation, currency fluctuations and new or increased tariffs, could adversely affect demand for our products. We continue to monitor the Russia-Ukraine war and the associated sanctions and other restrictions. We also are monitoring the Israel-Hamas war. Although we have no operations in Russia, Ukraine or Israel, certain of our customers and suppliers have been negatively impacted by these events, which in turn has impacted markets where we do business, including EMEA and Asia. The economic sanctions imposed on Russia have further increased existing global supply chain, logistics, and inflationary challenges. The full impact of the conflicts on our business operations and financial performance remains uncertain and will depend on future developments, including the severity and duration of the conflicts and their impact on regional and global economic conditions. We will continue to monitor the conflicts and assess the related restrictions and other effects on our employees, customers, and business.

Global Supply Chain Disruptions

Due to various factors that are beyond our control, there continues to be global supply chain disruptions, including a worldwide semiconductor supply shortage. In addition, we have experienced, and may continue to experience, business interruptions, including customer shutdowns and increased material and logistics costs and labor shortages. The semiconductor supply shortage is due, in part, to increased demand across multiple industries, including the automotive industry, resulting in a slowdown in their production schedules. The semiconductor supply shortage is also impacting our supply chain and our ability to meet demand at some of our non-automotive customers. We expect this semiconductor shortage to have a continued impact on our operating results and financial condition in fiscal 2024.

Acquisition of Nordic Lights

We acquired 92.2% of the outstanding shares of Nordic Lights on April 20, 2023. We acquired the remaining 7.8% of the outstanding shares of Nordic Lights in the six months ended October 28, 2023. Accordingly, as of October 28, 2023, we own 100% of Nordic Lights. The results of operations of Nordic Lights are reported within the Industrial segment. For further information, see Note 3, “Acquisition and Disposition” to the condensed consolidated financial statements included in this Report.

26

Consolidated Results of Operations

The table below compares our results of operations between the three and six months ended October 28, 2023 and the three and six months ended October 29, 2022:

	Three Months Ended						Six Months Ended
(in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales	$	288.0		$	315.9		$	577.7		$	598.3
Cost of products sold		235.7			241.8			471.4			462.4
Gross profit		52.3			74.1			106.3			135.9
Selling and administrative expenses		40.9			36.6			85.4			71.9
Goodwill impairment		56.5			—			56.5			—
Amortization of intangibles		6.2			4.7			11.9			9.4
Interest expense, net		4.4			0.5			7.2			0.5
Other income, net		(0.2	)		(1.1	)		(0.2	)		(5.2	)
Income tax (benefit) expense		(0.2	)		5.8			(0.1	)		10.2
Net (loss) income		(55.3	)		27.6			(54.4	)		49.1
Net income attributable to redeemable noncontrolling interest		—			—			—			—
Net (loss) income attributable to Methode	$	(55.3	)	$	27.6		$	(54.4	)	$	49.1

Net sales

Net sales decreased $27.9 million, or 8.8%, to $288.0 million in the three months ended October 28, 2023, compared to $315.9 million in the three months ended October 29, 2022. The decrease was primarily due to lower sales volumes in the Automotive segment, partially offset by the acquisition of Nordic Lights, which contributed $20.9 million of net sales to the Industrial segment, and favorable foreign currency translation of $3.5 million. Net sales included customer cost recoveries from spot buys of materials and premium freight costs of $0.6 million in the three months ended October 28, 2023, compared to $5.8 million in the three months ended October 29, 2022. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales decreased $47.1 million, or 15.2%.

Net sales decreased $20.6 million, or 3.4%, to $577.7 million in the six months ended October 28, 2023, compared to $598.3 million in the six months ended October 29, 2022. The decrease was primarily due to lower sales volumes in the Automotive segment, partially offset by the acquisition of Nordic Lights, which contributed $42.1 million of net sales to the Industrial segment, and favorable foreign currency translation of $4.0 million. Net sales included customer cost recoveries from spot buys of materials and premium freight costs of $1.3 million in the six months ended October 28, 2023, compared to $16.9 million in the six months ended October 29, 2022. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales decreased $51.1 million, or 8.8%.

Cost of products sold

Cost of products sold decreased $6.1 million, or 2.5%, to $235.7 million (81.8% of net sales) in the three months ended October 28, 2023, compared to $241.8 million (76.5% of net sales) in the three months ended October 29, 2022. Excluding the acquisition of Nordic Lights, which accounted for $14.9 million, and foreign currency translation of $2.5 million, cost of products sold decreased $23.5 million. The decrease was primarily due to lower material costs as a result of a decrease in sales volumes, partially offset by higher salary, freight and operating expenses. Restructuring costs were $0.2 million in the three months ended October 28, 2023, compared to $0.1 million in the three months ended October 29, 2022.

Cost of products sold increased $9.0 million, or 1.9%, to $471.4 million (81.6% of net sales) in the six months ended October 28, 2023, compared to $462.4 million (77.3% of net sales) in the six months ended October 29, 2022. Excluding the acquisition of Nordic Lights, which accounted for $30.8 million, and foreign currency translation of $2.9 million, cost of products sold decreased $24.7 million. The decrease was primarily due to lower material costs as a result of a decrease in sales volumes, partially offset by higher salary, freight and operating expenses. Restructuring costs were $0.8 million in the six months ended October 28, 2023, compared to $0.1 million in the six months ended October 29, 2022.

27

Gross profit margin

Gross profit margin was 18.2% of net sales in the three months ended October 28, 2023, compared to 23.5% of net sales in the three months ended October 29, 2022. The decrease in gross profit margin was primarily a result of lower sales and operational inefficiencies in the Automotive segment. The operational inefficiencies were caused mainly by higher labor costs and premium freight.

Gross profit margin was 18.4% of net sales in the six months ended October 28, 2023, compared to 22.7% of net sales in the six months ended October 29, 2022. The decrease in gross profit margin was primarily a result of lower sales and operational inefficiencies in the Automotive segment. The operational inefficiencies were caused mainly by labor and vendor issues which led to planning deficiencies, inventory shortages, unrecoverable spot purchases and premium freight, and delayed shipments.

Selling and administrative expenses

Selling and administrative expenses increased $4.3 million, or 11.7%, to $40.9 million (14.2% of net sales) in the three months ended October 28, 2023, compared to $36.6 million (11.6% of net sales) in the three months ended October 29, 2022. The acquisition of Nordic Lights and foreign currency translation accounted for $2.6 million and $1.0 million, respectively, of the increase. Excluding Nordic Lights and foreign currency translation, selling and administrative expenses increased $0.7 million primarily due to higher professional fees, partially offset by lower incentive and stock-based compensation expense. Restructuring costs were $0.4 million in both the three months ended October 28, 2023 and the three months ended October 29, 2022.

Selling and administrative expenses increased $13.5 million, or 18.8%, to $85.4 million (14.8% of net sales) in the six months ended October 28, 2023, compared to $71.9 million (12.0% of net sales) in the six months ended October 29, 2022. The acquisition of Nordic Lights and foreign currency translation accounted for $4.6 million and $1.6 million, respectively, of the increase. Excluding Nordic Lights and foreign currency translation, selling and administrative expenses increased $7.3 million. The increase was primarily due to higher professional fees, outbound freight expense and salary expense, partially offset by lower incentive and stock-based compensation expense. Restructuring costs were $0.5 million in both the six months ended October 28, 2023 and the six months ended October 29, 2022.

Goodwill impairment

In the three and six months ended October 28, 2023, we recognized a goodwill impairment of $56.5 million in the Automotive segment. For further information, see Note 6, "Goodwill and Other Intangible Assets" to the condensed consolidated financial statements included in this Report.

Amortization of intangibles

Amortization of intangibles was $6.2 million in the three months ended October 28, 2023, compared to $4.7 million in the three months ended October 29, 2022. Amortization of intangibles was $11.9 million in the six months ended October 28, 2023, compared to $9.4 million in the six months ended October 29, 2022. The increase in both periods was due to the recognition of amortization expense associated with the acquisition of Nordic Lights.

Interest expense, net

Interest expense, net was $4.4 million in the three months ended October 28, 2023, compared to $0.5 million in the three months ended October 29, 2022. Interest expense, net was $7.2 million in the six months ended October 28, 2023, compared to $0.5 million in the six months ended October 29, 2022. The increase in both periods was due to higher level of borrowings and increasing interest rates.

Other income, net

Other income, net was $0.2 million in the three months ended October 28, 2023, compared to $1.1 million in the three months ended October 29, 2022. Net foreign exchange gain was $0.3 million in the three months ended October 28, 2023, compared to $0.9 million in the three months ended October 29, 2022. In the three months ended October 28, 2023, we recognized a $0.6 million loss on the sale of certain assets of Dabir.

Other income, net was $0.2 million in the six months ended October 28, 2023, compared to $5.2 million in the six months ended October 29, 2022. Net foreign exchange gain was $0.5 million in the six months ended October 28, 2023, compared to $0.9 million in the six months ended October 29, 2022. In the six months ended October 28, 2023, we received $0.1 million of international government assistance, compared to $4.3 million in the six months ended October 29, 2022. In the six months ended October 28, 2023, we recognized a $0.6 million loss on the sale of certain assets of Dabir.

28

Income tax (benefit) expense

Income tax benefit was $0.2 million (0.4% effective tax rate) in the three months ended October 28, 2023, compared to income tax expense of $5.8 million (17.4% effective tax rate) in the three months ended October 29, 2022. Income tax benefit was $0.1 million (0.2% effective tax rate) in the six months ended October 28, 2023, compared to income tax expense of $10.2 million (17.2% effective tax rate) in the six months ended October 29, 2022.

The effective tax rate for the three and six months ended October 28, 2023 was lower than the U.S. federal statutory tax rate of 21% primarily due to the impact of an impairment of goodwill which is non-deductible for tax purposes, income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions offset by global intangible low-tax income. The effective tax rate for the three and six months ended October 29, 2022 was lower than the U.S. federal statutory tax rate of 21% primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses.

Net (loss) income

Net loss was $55.3 million in the three months ended October 28, 2023, compared to net income of $27.6 million in the three months ended October 29, 2022. The acquisition of Nordic Lights contributed $0.8 million of net income. Excluding Nordic Lights, net income decreased $83.7 million as a result of the reasons described above.

Net loss was $54.4 million in the six months ended October 28, 2023, compared to net income of $49.1 million in the six months ended October 29, 2022. The acquisition of Nordic Lights contributed $1.9 million of net income and the impact of foreign currency translation was $0.2 million. Excluding Nordic Lights and foreign currency translation, net income decreased $105.4 million as a result of the reasons described above.

Reportable Operating Segments

Automotive

	Three Months Ended						Six Months Ended
($ in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales
North America	$	70.9		$	97.8		$	137.7		$	192.5
Europe, the Middle East & Africa ("EMEA")		49.7			53.9			101.9			106.0
Asia		33.7			45.2			73.0			75.0
Net sales		154.3			196.9			312.6			373.5
Gross profit	$	11.6		$	38.3		$	26.9		$	67.7
As a percent of net sales		7.5	%		19.5	%		8.6	%		18.1	%
(Loss) income from operations	$	(61.5	)	$	23.4		$	(64.3	)	$	38.1
As a percent of net sales		(39.9	)%		11.9	%		(20.6	)%		10.2	%
Customer cost recoveries:
North America	$	—		$	1.5		$	—		$	9.4
EMEA		0.3			0.1			0.5			1.3
Asia		—			0.6			—			0.6
Total	$	0.3		$	2.2		$	0.5		$	11.3

29

Net sales

Automotive segment net sales decreased $42.6 million, or 21.6%, to $154.3 million in the three months ended October 28, 2023, compared to $196.9 million in the three months ended October 29, 2022. Excluding foreign currency translation and customer cost recoveries, net sales decreased $42.9 million, or 22.0%.

Net sales in North America decreased $26.9 million to $70.9 million in the three months ended October 28, 2023, compared to $97.8 million in the three months ended October 29, 2022. Excluding customer cost recoveries, net sales decreased $25.4 million primarily due to lower sales volumes from program roll-offs. Net sales in EMEA decreased $4.2 million to $49.7 million in the three months ended October 28, 2023, compared to $53.9 million in the three months ended October 29, 2022. The stronger euro, relative to the U.S. dollar, increased net sales in EMEA by $3.6 million. Excluding foreign currency translation and customer cost recoveries, net sales in EMEA decreased $8.0 million due to lower sales volumes of sensor products, partially offset by higher sales volumes of user interface and switch products. Net sales in Asia decreased $11.5 million to $33.7 million in the three months ended October 28, 2023, compared to $45.2 million in the three months ended October 29, 2022. The weaker Chinese renminbi, relative to the U.S. dollar, decreased net sales in Asia by $1.4 million. Excluding foreign currency translation and customer cost recoveries, Asia net sales decreased $9.5 million due to a program roll-off and lower sales volumes of overhead consoles.

Automotive segment net sales decreased $60.9 million, or 16.3%, to $312.6 million in the six months ended October 28, 2023, compared to $373.5 million in the six months ended October 29, 2022. Excluding foreign currency translation and customer cost recoveries, net sales decreased $52.3 million, or 14.4%.

Net sales in North America decreased $54.8 million to $137.7 million in the six months ended October 28, 2023, compared to $192.5 million in the six months ended October 29, 2022. Excluding customer cost recoveries, net sales decreased $45.4 million primarily due to lower sales volumes from program roll-offs. Net sales in EMEA decreased $4.1 million to $101.9 million in the six months ended October 28, 2023, compared to $106.0 million in the six months ended October 29, 2022. The stronger euro, relative to the U.S. dollar, increased net sales in EMEA by $5.9 million. Excluding foreign currency translation and customer cost recoveries, net sales in EMEA decreased $9.2 million due to lower sales volumes of sensor products, partially offset by higher sales volumes of user interface and switch products. Net sales in Asia decreased $2.0 million to $73.0 million in the six months ended October 28, 2023, compared to $75.0 million in the six months ended October 29, 2022. The weaker Chinese renminbi, relative to the U.S. dollar, decreased net sales in Asia by $3.7 million. Excluding foreign currency translation and customer cost recoveries, Asia net sales increased $2.3 million primarily due to higher lead frame sales.

Gross profit

Automotive segment gross profit decreased $26.7 million, or 69.7%, to $11.6 million in the three months ended October 28, 2023, compared to $38.3 million in the three months ended October 29, 2022. Excluding the impact of foreign currency translation, gross profit decreased $27.1 million. Gross profit margins decreased to 7.5% in the three months ended October 28, 2023, compared to 19.5% in the three months ended October 29, 2022.

Automotive segment gross profit decreased $40.8 million, or 60.3%, to $26.9 million in the six months ended October 28, 2023, compared to $67.7 million in the six months ended October 29, 2022. Excluding the impact of foreign currency translation, gross profit decreased $41.4 million. Gross profit margins decreased to 8.6% in the six months ended October 28, 2023, compared to 18.1% in the six months ended October 29, 2022.

The decrease in gross profit margins in both periods was due to lower sales volumes and operational inefficiencies in North America caused mainly by labor and vendor issues which led to planning deficiencies, inventory shortages, unrecoverable spot purchases and premium freight, and delayed shipments.

(Loss) income from operations

Automotive segment loss from operations was $61.5 million in the three months ended October 28, 2023, compared to income of $23.4 million in the three months ended October 29, 2022. Loss from operations in the three months ended October 28, 2023, includes goodwill impairment of $56.5 million. Excluding goodwill impairment and the impact of foreign currency translation, income from operations decreased $28.2 million.

Automotive segment loss from operations was $64.3 million in the six months ended October 28, 2023, compared to income of $38.1 million in the six months ended October 29, 2022. Loss from operations in the six months ended October 28, 2023, includes goodwill impairment of $56.5 million. Excluding goodwill impairment and the impact of foreign currency translation, income from operations decreased $45.3 million.

The decrease in both periods was primarily due to lower gross profit and higher selling and administrative expenses. Selling and administrative expenses increased due to higher salary expense, outbound freight expense and restructuring costs, partially offset by lower incentive and stock-based compensation expense.

30

Industrial

	Three Months Ended						Six Months Ended
($ in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales	$	120.4		$	103.8		$	235.8		$	195.9
Gross profit	$	37.9		$	33.3		$	73.5		$	63.7
As a percent of net sales		31.5	%		32.1	%		31.2	%		32.5	%
Income from operations	$	25.7		$	25.0		$	49.9		$	47.4
As a percent of net sales		21.3	%		24.1	%		21.2	%		24.2	%
Customer cost recoveries	$	0.3		$	2.5		$	0.4		$	3.9

Net sales

Industrial segment net sales increased $16.6 million, or 16.0%, to $120.4 million in the three months ended October 28, 2023, compared to $103.8 million in the three months ended October 29, 2022. The increase was primarily due to the acquisition of Nordic Lights, which contributed $20.9 million of net sales, and foreign currency translation of $1.3 million, partially offset by lower customer cost recoveries from spot buys of materials and premium freight costs of $2.2 million. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales decreased $3.4 million, or 3.4%, primarily due to lower sales volumes of power distribution solutions for data centers.

Industrial segment net sales increased $39.9 million, or 20.4%, to $235.8 million in the six months ended October 28, 2023, compared to $195.9 million in the six months ended October 29, 2022. The increase was primarily due to the acquisition of Nordic Lights, which contributed $42.1 million of net sales, and foreign currency translation of $1.8 million, partially offset by lower customer cost recoveries from spot buys of materials and premium freight costs of $3.5 million. Excluding the impact of Nordic Lights, foreign currency translation and customer cost recoveries, net sales decreased $0.5 million, or 0.3%, primarily due to lower sales volumes of power distribution solutions for data centers, partially offset by higher sales volumes of commercial vehicle lighting solutions products.

Gross profit

Industrial segment gross profit increased $4.6 million, or 13.8%, to $37.9 million in the three months ended October 28, 2023, compared to $33.3 million in the three months ended October 29, 2022. The increase was due to the acquisition of Nordic Lights, which contributed $6.0 million of gross profit, and $0.6 million of favorable foreign currency translation. Excluding the impact of Nordic Lights and foreign currency translation, gross profit decreased $2.0 million. Gross profit margins decreased to 31.5% in the three months ended October 28, 2023, compared to 32.1% in the three months ended October 29, 2022. Gross profit margins were impacted by lower sales volumes and higher freight expense.

Industrial segment gross profit increased $9.8 million, or 15.4%, to $73.5 million in the six months ended October 28, 2023, compared to $63.7 million in the six months ended October 29, 2022. The increase was due to the acquisition of Nordic Lights, which contributed $11.3 million of gross profit, and $0.4 million of favorable foreign currency translation. Excluding the impact of Nordic Lights and foreign currency translation, gross profit decreased $1.9 million. Gross profit margins decreased to 31.2% in the six months ended October 28, 2023, compared to 32.5% in the six months ended October 29, 2022. Gross profit margins were impacted by lower sales volumes and higher freight expense.

Income from operations

Industrial segment income from operations increased $0.7 million, or 2.8%, to $25.7 million in the three months ended October 28, 2023, compared to $25.0 million in the three months ended October 29, 2022. The increase was due to the acquisition of Nordic Lights, which contributed $1.8 million of income from operations, and $0.4 million of favorable foreign currency translation. Excluding Nordic Lights and the impact of foreign currency translation, income from operations decreased $1.5 million due to lower gross profit, partially offset by lower selling and administrative expenses. The decrease in selling and administrative expenses was primarily due to $0.3 million of restructuring costs recognized in the three months ended October 29, 2022.

Industrial segment income from operations increased $2.5 million, or 5.3%, to $49.9 million in the six months ended October 28, 2023, compared to $47.4 million in the six months ended October 29, 2022. The increase was due to the acquisition of Nordic Lights, which contributed $4.0 million of income from operations, and $0.2 million of favorable foreign currency translation. Excluding Nordic Lights and the impact of foreign currency translation, income from operations decreased $1.7 million. The decrease was primarily due to lower gross profit, partially offset by lower selling and administrative expenses. The decrease in selling and administrative expenses was primarily due to $0.4 million of restructuring costs recognized in the six months ended October 29, 2022.

31

Interface

	Three Months Ended						Six Months Ended
($ in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales	$	11.7		$	14.1		$	26.9		$	27.1
Gross profit	$	1.9		$	2.5		$	5.5		$	4.7
As a percent of net sales		16.2	%		17.7	%		20.4	%		17.3	%
Income from operations	$	1.0		$	1.6		$	3.9		$	3.2
As a percent of net sales		8.5	%		11.3	%		14.5	%		11.8	%
Customer cost recoveries	$	—		$	1.1		$	0.4		$	1.7

Net sales

Interface segment net sales decreased $2.4 million, or 17.0% to $11.7 million in the three months ended October 28, 2023, compared to $14.1 million in the three months ended October 29, 2022. Excluding customer cost recoveries, net sales decreased $1.3 million, or 10.0%. The decrease was primarily due to lower sales volumes of data solution products, partially offset by higher sales volumes of appliance products.

Interface segment net sales decreased $0.2 million, or 0.7%, to $26.9 million in the six months ended October 28, 2023, compared to $27.1 million in the six months ended October 29, 2022. Excluding customer cost recoveries, net sales increased $1.1 million, or 4.3%. The increase was primarily due to higher sales volumes of appliance products, partially offset by lower sales volumes of data solution products.

Gross profit

Interface segment gross profit decreased $0.6 million, or 24.0%, to $1.9 million in the three months ended October 28, 2023, compared to $2.5 million in the three months ended October 29, 2022. Gross profit margins decreased to 16.2% in the three months ended October 28, 2023, compared to 17.7% in the three months ended October 29, 2022. The decrease in gross profit margins was primarily due to lower sales volumes.

Interface segment gross profit increased $0.8 million, or 17.0%, to $5.5 million in the six months ended October 28, 2023, compared to $4.7 million in the six months ended October 29, 2022. Gross profit margins increased to 20.4% in the six months ended October 28, 2023, compared to 17.3% in the six months ended October 29, 2022. The increase in gross profit margins was primarily due to higher sales volumes of appliance products.

Income from operations

Interface segment income from operations decreased $0.6 million, or 37.5%, to $1.0 million in the three months ended October 28, 2023, compared to $1.6 million in the three months ended October 29, 2022. The decrease was due to lower gross profit.

Interface segment income from operations increased $0.7 million, or 21.9%, to $3.9 million in the six months ended October 28, 2023, compared to $3.2 million in the six months ended October 29, 2022. The increase was due to higher gross profit.

Medical

	Three Months Ended						Six Months Ended
(in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales	$	1.6		$	1.1		$	2.4		$	1.8
Gross profit	$	0.6		$	(0.1	)	$	(0.1	)	$	(0.3	)
Loss from operations	$	(0.7	)	$	(1.4	)	$	(2.9	)	$	(2.9	)

In the first quarter of fiscal 2024, we made the decision to initiate the discontinuation of the Dabir business (which accounts for all of the Medical segment's financial results). Towards the end of the second quarter of fiscal 2024, we sold certain assets of the Dabir business and have now exited this business.

Net sales

Medical segment net sales increased $0.5 million to $1.6 million in the three months ended October 28, 2023, compared to $1.1 million in the three months ended October 29, 2022. Medical segment net sales increased $0.6 million to $2.4 million in the six months ended October 28, 2023, compared to $1.8 million in the six months ended October 29, 2022. The increase in both periods was due to last time buys from Dabir's customers.

32

Gross profit

Medical segment gross profit was $0.6 million in the three months ended October 28, 2023 compared to a loss of $0.1 million in the three months ended October 29, 2022. Higher gross profit was primarily due to higher sales volumes and lower operating costs. In addition, restructuring costs of $0.2 million were recognized in the three months ended October 28, 2023.

Medical segment gross profit was a loss of $0.1 million in the six months ended October 28, 2023 compared to a loss of $0.3 million in the six months ended October 29, 2022. The improvement was due to higher sales volumes in the six months ended October 28, 2023. In addition, restructuring costs of $0.8 million were recognized in the six months ended October 28, 2023.

Loss from operations

Medical segment loss from operations decreased $0.7 million to $0.7 million in the three months ended October 28, 2023, compared to $1.4 million in the three months ended October 29, 2022. The decrease in the loss was primarily due to higher gross profit.

Medical segment loss from operations was $2.9 million in both the six months ended October 28, 2023 and the six months ended October 29, 2022.

Financial Condition, Liquidity and Capital Resources

Our liquidity requirements are primarily to fund our business operations, including capital expenditures and working capital requirements, as well as to fund debt service requirements, dividends and stock repurchases. Our primary sources of liquidity are cash flows from operations, existing cash balances and borrowings under our senior unsecured credit agreement. We believe our liquidity position will be sufficient to fund our existing operations and current commitments for at least the next twelve months. However, if economic conditions remain impacted for longer than we expect due to supply chain disruptions, inflationary pressure or other geopolitical risks, including the Russia-Ukraine war and Israel-Hamas war, our liquidity position could be severely impacted.

As of October 28, 2023, we had $122.5 million of cash and cash equivalents, of which $107.4 million was held in subsidiaries outside the U.S. Cash held by these subsidiaries is used to fund operational activities and can be repatriated, primarily through the payment of dividends and the repayment of intercompany loans, without creating material additional income tax expense.

Share Buyback Program

The Board of Directors authorized a program to purchase up to $200.0 million of our outstanding common stock through June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. As of October 28, 2023, a total of 3,113,154 shares have been purchased at a total cost of $127.1 million since the commencement of the share buyback program. As of October 28, 2023, the dollar value of shares that remained available to be purchased under this share buyback program was $72.9 million.

Credit Agreement

On October 31, 2022, we entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amends and restates the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), with Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750,000,000, (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement. In addition, the Credit Agreement permits us to increase the revolving commitments and/or add one or more tranches of term loans under the Credit Agreement from time to time by up to an amount equal to (i) $250,000,000 plus (ii) an additional amount so long as the leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Credit Agreement matures on October 31, 2027.

As of October 28, 2023, $330.6 million was outstanding under the revolving credit facility. We were in compliance with all covenants under the Credit Agreement as of October 28, 2023. For further information, see Note 8, “Debt” to the condensed consolidated financial statements included in this Report.

33

Cash Flows

	Six Months Ended
(in millions)	October 28, 2023			October 29, 2022
Operating activities:
Net (loss) income	$	(54.4	)	$	49.1
Non-cash items		89.9			33.0
Changes in operating assets and liabilities		(41.7	)		(54.0	)
Net cash (used in) provided by operating activities		(6.2	)		28.1
Net cash used in investing activities		(22.3	)		(14.5	)
Net cash provided by (used in) financing activities		1.9			(48.7	)
Effect of foreign currency exchange rate changes on cash and cash equivalents		(7.9	)		(7.3	)
Decrease in cash and cash equivalents		(34.5	)		(42.4	)
Cash and cash equivalents at beginning of the period		157.0			172.0
Cash and cash equivalents at end of the period	$	122.5		$	129.6

Operating activities

Net cash used in operating activities was $6.2 million in the six months ended October 28, 2023, compared to net cash provided by operating activities of $28.1 million in the six months ended October 29, 2022. The decrease was due to lower net income adjusted for non-cash items. The $41.7 million of cash outflows for operating assets and liabilities in the six months ended October 28, 2023 was primarily due to higher inventory, prepaid expenses and lower accounts payable and other liabilities, partially offset by lower accounts receivable.

Investing activities

Net cash used in investing activities was $22.3 million in the six months ended October 28, 2023, compared to $14.5 million in the six months ended October 29, 2022. Capital expenditures were $24.5 million in the six months ended October 28, 2023, compared to $18.0 million in the six months ended October 29, 2022.

Financing activities

Net cash provided by financing activities was $1.9 million in the six months ended October 28, 2023, compared to net cash used in financing activities of $48.7 million in the six months ended October 29, 2022. In the six months ended October 28, 2023, we used $7.8 million of cash for the purchase of shares under our share buyback program, compared to $31.6 million in the six months ended October 29, 2022. We paid cash dividends of $10.1 million in the six months ended October 28, 2023, compared to $9.9 million in the six months ended October 29, 2022. In the six months ended October 28, 2023, we had net borrowings of $34.6 million, compared to net repayments of borrowings of $6.5 million in the six months ended October 29, 2022. In addition, we paid $10.9 million for the purchase of redeemable noncontrolling interests related to Nordic Lights.

Recent Accounting Pronouncements

See Note 1, “Description of Business and Summary of Significant Accounting Policies” to the condensed consolidated financial statements included in Item 1.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as defined under SEC rules.

Legal Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. We became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, we terminated all of our agreements with the Fuchs companies. On June 20, 2014, we filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, we amended our complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

34

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties have filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. We opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court heard arguments in this matter on March 21, 2023. On June 29, 2023, the Supreme Court vacated the Tenth Circuit’s August 2021 decision and remanded the matter back to the Tenth Circuit for further proceedings. On September 1, 2023, the Tenth Circuit requested supplemental briefing from the parties regarding the effect of the Supreme Court’s decision on the appeal and the proper course of further proceedings. That briefing was thereafter submitted.

Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that we will be able to collect all or any portion of the judgment. Furthermore, defendants Abitron Germany and Hetronic Germany filed for insolvency in German court in September and October 2023 respectively, and the Germany insolvency court then appointed a receiver. These insolvency proceedings could potentially adversely impact our ability to enforce or collect upon the judgment or portions of the judgment or otherwise pursue or enforce claims or rights against those defendants.

In the six months ended October 28, 2023 and October 29, 2022, we incurred Hetronic-related legal fees of $0.9 million and $0.8 million, respectively. These amounts are included in the selling and administrative expenses in the Industrial segment.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risks from foreign currency exchange, interest rates, and commodity prices, which could affect our operating results, financial position and cash flows. We manage a portion of these risks through use of derivative financial instruments in accordance with our policies. We do not enter into derivative financial instruments for speculative or trading purposes.

There has been no significant change in our exposure to market risk during the six months ended October 28, 2023. For a discussion of our exposure to market risk, refer to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” contained in our Annual Report on Form 10-K for the year ended April 29, 2023.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report on Form 10-Q, we performed an evaluation under the supervision and with the participation of the Company’s management, including our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Our disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s applicable rules and forms. As a result of this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were not effective as of October 28, 2023 due to the previously reported material weakness that was disclosed in our Annual Report on Form 10-K for the year ended April 29, 2023.

Notwithstanding the identified material weakness, management, including our CEO and CFO, believe that the condensed consolidated financial statements contained in this Quarterly Report fairly present, in all material respects, our financial condition, results of operations and cash flows for the fiscal period presented in conformity with GAAP.

35

Previously Disclosed Material Weakness

As previously disclosed in our Annual Report on Form 10-K for the year ended April 29, 2023, our management concluded that our internal controls over financial reporting were not effective as of April 29, 2023 due to a material weakness. The material weakness related to revenue at a business unit in our Automotive segment. Specifically, we did not maintain effective review, approval and validation controls over pricing data entered into the business unit's financial system and non-standard contract terms.

We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that this material weakness is remediated as soon as possible. We believe we have made progress towards remediation and continue to implement our remediation plan for the material weakness in internal control over financial reporting. Remediation efforts to date include the following:

•Adding additional internal controls over the review, approval and validation of customer pricing data and non-standard contract terms.

•Developing and deploying additional training programs around the operation and importance of internal controls.

As we continue to evaluate and work to improve our internal control over financial reporting, management may determine to take additional measures to strengthen controls or to modify the remediation plan described above. When fully implemented and operational, we believe the controls we have designed or plan to design will remediate the control deficiency that has led to the material weakness we have identified and strengthen our internal controls over financial reporting. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

Changes in Internal Control over Financial Reporting

Except as described above, there have been no changes in our internal control over financial reporting during the three months ended October 28, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

36

PART II. OTHER INFORMATION

Item 1A. Risk Factors

Our business, financial condition, results of operations and cash flows are subject to various ‎risks which could cause actual results to vary from recent results or from anticipated future results. There have ‎been no material changes to the risk factors previously disclosed in Part I - Item 1A, “Risk Factors” of our Form 10-K for the ‎year ended April 29, 2023.‎

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The Board of Directors authorized a program to purchase of up to $200.0 million of the Company’s outstanding common stock through June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. As of October 28, 2023, we purchased and retired $127.1 million of common stock since the commencement of the share buyback program.

The following table provides information about our purchases of equity securities during the three months ended October 28, 2023.

Period	Total number of shares purchased1		Average price paid per share		Total number of shares purchased as part of publicly announced plan		Approximate dollar value of shares that may yet be purchased under the program (in millions)
July 30, 2023 through August 26, 2023		—	$	—		—	$	80.7
August 27, 2023 through September 30, 2023		34,744	$	21.6		34,744	$	79.9
October 1, 2023 through October 28, 2023		288,035	$	24.3		288,035	$	72.9
(1) In addition to open-market purchases, 193 shares of common stock were surrendered by employees to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Item 5. Other Information

During our last fiscal quarter, no director or officer of the Company, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of Regulation S-K.

Item 6. Exhibits

Exhibit Number	Description
10.1**	Retention, Transition Services and Consulting Agreement between the Company and Donald W. Duda dated August 31, 2023 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on August 31, 2023).
10.2**	Form of Retention Bonus Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on September 18, 2023).
31.1	Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
32*	Certification of Periodic Financial Report Pursuant to 18 U.S.C. Section 1350.
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*	Indicates that the exhibit is being furnished with this report and not filed as part of it.
**	Management compensatory plan.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		METHODE ELECTRONICS, INC.
		By:	/s/ Ronald L.G. Tsoumas
			Ronald L.G. Tsoumas
			Chief Financial Officer
			(Principal Financial Officer)
Dated:	December 7, 2023

38

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Donald W. Duda, certify that:

1.I have reviewed this report on Form 10-Q of Methode Electronics, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: December 7, 2023	By:	/s/ Donald W. Duda
		Donald W. Duda
		Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Ronald L.G. Tsoumas, certify that:

1.I have reviewed this report on Form 10-Q of Methode Electronics, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: December 7, 2023	By:	/s/ Ronald L.G. Tsoumas
		Ronald L. G. Tsoumas
		Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Methode Electronics, Inc. (the “Company”) certifies that the Quarterly Report on Form 10-Q of the Company for the quarter ended October 28, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

.

Date: December 7, 2023	By:	/s/ Donald W. Duda
		Donald W. Duda Chief Executive Officer
Date: December 7, 2023	By:	/s/ Ronald L.G. Tsoumas
		Ronald L. G. Tsoumas
		Chief Financial Officer

XML

Cover Page - shares	6 Months Ended
	Oct. 28, 2023	Dec. 04, 2023
Cover [Abstract]
Entity Registrant Name	METHODE ELECTRONICS, INC.
Entity Central Index Key	0000065270
Document Type	10-Q
Document Period End Date	Oct. 28, 2023
Amendment Flag	false
Current Fiscal Year End Date	--04-27
Entity Current Reporting Status	Yes
Trading Symbol	MEI
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		35,599,426
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity File Number	001-33731
Entity Tax Identification Number	36-2090085
Entity Address, Address Line One	8750 West Bryn Mawr Avenue
Entity Address, Address Line Two	Suite 1000
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60631-3518
City Area Code	708
Local Phone Number	867-6777
Entity Incorporation, State or Country Code	DE
Entity Interactive Data Current	Yes
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	Common Stock, $0.50 Par Value
Security Exchange Name	NYSE

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Income Statement [Abstract]
Net sales	$ 288.0	$ 315.9	$ 577.7	$ 598.3
Cost of products sold	235.7	241.8	471.4	462.4
Gross profit	52.3	74.1	106.3	135.9
Selling and administrative expenses	40.9	36.6	85.4	71.9
Goodwill impairment	56.5		56.5
Amortization of intangibles	6.2	4.7	11.9	9.4
(Loss) income from operations	(51.3)	32.8	(47.5)	54.6
Interest expense, net	4.4	0.5	7.2	0.5
Other income, net	(0.2)	(1.1)	(0.2)	(5.2)
Pre-tax (loss) income	(55.5)	33.4	(54.5)	59.3
Income tax (benefit) expense	(0.2)	5.8	(0.1)	10.2
Net (loss) income	(55.3)	27.6	(54.4)	49.1
Net (loss) income attributable to Methode	$ (55.3)	$ 27.6	$ (54.4)	$ 49.1
(Loss) income per share attributable to Methode:
Basic	$ (1.55)	$ 0.76	$ (1.52)	$ 1.35
Diluted	(1.55)	0.75	(1.52)	1.33
Cash dividends per share	$ 0.14	$ 0.14	$ 0.28	$ 0.28

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (55.3)	$ 27.6	$ (54.4)	$ 49.1
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(20.2)	(19.7)	(22.7)	(30.6)
Derivative financial instruments	0.4	1.6	(1.2)	3.1
Net other comprehensive income (loss)	(19.8)	(18.1)	(23.9)	(27.5)
Comprehensive (loss) income	(75.1)	9.5	(78.3)	21.6
Comprehensive income attributable to redeemable noncontrolling interest	0.0	0.0	0.0	0.0
Comprehensive (loss) income attributable to Methode	$ (75.1)	$ 9.5	$ (78.3)	$ 21.6

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Current assets:
Cash and cash equivalents	$ 122.5	$ 157.0
Accounts receivable, net	292.3	314.3
Inventories	183.9	159.7
Income tax receivable	16.7	12.9
Prepaid expenses and other current assets	21.1	20.5
Total current assets	636.5	664.4
Long-term assets:
Property, plant and equipment, net	224.6	220.3
Goodwill	220.7	301.9
Other intangible assets, net	264.7	256.7
Operating lease right-of-use assets, net	26.9	28.4
Deferred tax assets	33.0	33.6
Pre-production costs	44.5	36.1
Other long-term assets	34.0	37.7
Total long-term assets	848.4	914.7
Total assets	1,484.9	1,579.1
Current liabilities:
Accounts payable	133.5	138.7
Accrued employee liabilities	29.0	36.7
Other accrued liabilities	38.7	34.5
Short-term operating lease liabilities	6.6	6.8
Short-term debt	3.0	3.2
Income tax payable	7.5	8.1
Total current liabilities	218.3	228.0
Long-term liabilities:
Long-term debt	329.0	303.6
Long-term operating lease liabilities	20.9	21.8
Long-term income tax payable	9.3	16.7
Other long-term liabilities	16.5	14.3
Deferred tax liabilities	46.0	41.8
Total long-term liabilities	421.7	398.2
Total liabilities	640.0	626.2
Redeemable noncontrolling interest		11.1
Shareholders' equity:
Common stock, $0.50 par value, 100,000,000 shares authorized, 37,034,050 shares and 37,167,375 shares issued as of October 28, 2023 and April 29, 2023, respectively	18.5	18.6
Additional paid-in capital	183.8	181.0
Accumulated other comprehensive loss	(42.9)	(19.0)
Treasury stock, 1,346,624 shares as of October 28, 2023 and April 29, 2023	(11.5)	(11.5)
Retained earnings	697.0	772.7
Total shareholders' equity	844.9	941.8
Total liabilities and shareholders' equity	$ 1,484.9	$ 1,579.1

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Oct. 28, 2023	Apr. 29, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.50	$ 0.50
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	37,034,050	37,167,375
Treasury stock, shares	1,346,624	1,346,624

XML

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Redeemable Noncontrolling Interest	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Treasury stock	Retained Earnings
Beginning balance at Apr. 30, 2022	$ 913.8		$ 19.2	$ 169.0	$ (26.8)	$ (11.5)	$ 763.9
Beginning balance (in shares) at Apr. 30, 2022			38,276,968
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(0.4)						(0.4)
Issuance of restricted stock, net of tax withholding (in shares)			54,479
Purchases of common stock	$ (31.6)		$ (0.5)				(31.1)
Purchases of common stock (in shares)	(825,814)		(825,814)
Stock-based compensation expense	$ 5.7			5.7
Other comprehensive loss	(27.5)				(27.5)
Net Income (Loss)	49.1						49.1
Dividends on common stock	(10.3)						(10.3)
Ending balance at Oct. 29, 2022	898.8		$ 18.7	174.7	(54.3)	(11.5)	771.2
Ending balance (in shares) at Oct. 29, 2022			37,505,633
Beginning balance at Jul. 30, 2022	911.4		$ 19.0	172.0	(36.2)	(11.5)	768.1
Beginning balance (in shares) at Jul. 30, 2022			38,001,714
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding (in shares)			12,098
Purchases of common stock	$ (19.7)		$ (0.3)				(19.4)
Purchases of common stock (in shares)	(508,179)		(508,179)
Stock-based compensation expense	$ 2.7			2.7
Other comprehensive loss	(18.1)				(18.1)
Net Income (Loss)	27.6						27.6
Dividends on common stock	(5.1)						(5.1)
Ending balance at Oct. 29, 2022	898.8		$ 18.7	174.7	(54.3)	(11.5)	771.2
Ending balance (in shares) at Oct. 29, 2022			37,505,633
Beginning balance at Apr. 29, 2023	941.8		$ 18.6	181.0	(19.0)	(11.5)	772.7
Beginning Balance at Apr. 29, 2023		$ 11.1
Beginning balance (in shares) at Apr. 29, 2023			37,167,375
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(3.8)		$ 0.1	(0.1)			(3.8)
Issuance of restricted stock, net of tax withholding (in shares)			189,454
Purchase of redeemable noncontrolling interest		(11.1)
Purchases of common stock	$ (7.8)		$ (0.2)				(7.6)
Purchases of common stock (in shares)	(322,779)		(322,779)
Stock-based compensation expense	$ 2.9			2.9
Other comprehensive loss	(23.9)				(23.9)
Net Income (Loss)	(54.4)						(54.4)
Dividends on common stock	(9.9)						(9.9)
Ending balance at Oct. 28, 2023	844.9		$ 18.5	183.8	(42.9)	(11.5)	697.0
Ending balance (in shares) at Oct. 28, 2023			37,034,050
Beginning balance at Jul. 29, 2023	931.4		$ 18.7	182.5	(23.1)	(11.5)	764.8
Beginning Balance at Jul. 29, 2023		0.9
Beginning balance (in shares) at Jul. 29, 2023			37,356,156
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding (in shares)			673
Purchase of redeemable noncontrolling interest		$ (0.9)
Purchases of common stock	$ (7.8)		$ (0.2)				(7.6)
Purchases of common stock (in shares)	(322,779)		(322,779)
Stock-based compensation expense	$ 1.3			1.3
Other comprehensive loss	(19.8)				(19.8)
Net Income (Loss)	(55.3)						(55.3)
Dividends on common stock	(4.9)						(4.9)
Ending balance at Oct. 28, 2023	$ 844.9		$ 18.5	$ 183.8	$ (42.9)	$ (11.5)	$ 697.0
Ending balance (in shares) at Oct. 28, 2023			37,034,050

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022
Operating activities:
Net (loss) income	$ (54.4)	$ 49.1
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	28.4	24.5
Stock-based compensation expense	3.9	6.7
Change in cash surrender value of life insurance	0.2	(0.2)
Amortization of debt issuance costs	0.4	0.3
Loss on sale of property, plant and equipment	0.5	0.1
Impairment of long-lived assets	0.6	0.4
Goodwill impairment	56.5
Change in deferred income taxes	(1.0)	1.0
Other	0.8	0.2
Changes in operating assets and liabilities:
Accounts receivable	12.5	(50.6)
Inventories	(29.1)	(19.5)
Prepaid expenses and other assets	(10.8)	(15.7)
Accounts payable	(1.8)	21.5
Other liabilities	(12.5)	10.3
Net cash (used in) provided by operating activities	(6.2)	28.1
Investing activities:
Purchases of property, plant and equipment	(24.5)	(18.0)
Proceeds from settlement of net investment hedge	0.6
Proceeds from disposition of assets	1.6	3.5
Net cash used in investing activities	(22.3)	(14.5)
Financing activities:
Taxes paid related to net share settlement of equity awards	(3.8)	(0.5)
Repayments of finance leases	(0.1)	(0.2)
Purchases of common stock	(7.8)	(31.6)
Cash dividends	(10.1)	(9.9)
Purchase of redeemable noncontrolling interest	(10.9)
Proceeds from borrowings	213.9
Repayments of borrowings	(179.3)	(6.5)
Net cash provided by (used in) financing activities	1.9	(48.7)
Effect of foreign currency exchange rate changes on cash and cash equivalents	(7.9)	(7.3)
Decrease in cash and cash equivalents	(34.5)	(42.4)
Cash and cash equivalents at beginning of the period	157.0	172.0
Cash and cash equivalents at end of the period	122.5	129.6
Cash paid during the period for:
Interest	6.7	1.4
Income taxes, net of refunds	14.5	12.5
Operating lease obligations	$ 4.5	$ 4.0

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (55.3)	$ 27.6	$ (54.4)	$ 49.1

XML

Insider Trading Arrangements	6 Months Ended
	Oct. 28, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Description of Business and Summary of Significant Accounting Policies

6 Months Ended

Oct. 28, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business and Summary of Significant Accounting Policies

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of business

Methode Electronics, Inc. (the “Company” or “Methode”) is a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. The Company designs, engineers and produces mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing its broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

The Company’s solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment and consumer appliance.

Basis of presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany balances and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair presentation of the results of operations, financial position and cash flows of the Company for the interim periods presented. These financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Form 10-K for the year ended April 29, 2023, filed with the SEC on June 27, 2023. Results may vary from quarter to quarter for reasons other than seasonality.

Financial reporting periods

The Company maintains its financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. The three months ended October 28, 2023 and October 29, 2022 were both 13-week periods and the six months ended October 28, 2023 and October 29, 2022 were both 26-week periods.

Use of estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. These estimates and assumptions are subject to an inherent degree of uncertainty and may change, as new events occur, and additional information is obtained. As a result, actual results may differ from previously estimated amounts, and such differences may be material to the condensed consolidated financial statements.

Recently adopted accounting pronouncements

In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, “Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Accounting Standards Codification ("ASC") 606, as if the acquirer had originated the contracts. Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. The Company adopted this ASU in the first quarter of fiscal 2024 on a prospective basis. The adoption of this ASU did not have a material impact on its condensed consolidated financial statements or related disclosures and is only applicable to future business acquisitions.

New accounting pronouncements not yet adopted

In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which requires public entities to disclose information about their reportable segments’ significant expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. Early adoption is permitted. The adoption of this ASU will result in increased disclosures for the Company's segments.

There have been no other newly issued or newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements. Further, at October 28, 2023, there are no other pronouncements pending adoption that are expected to have a material impact on the Company’s condensed consolidated financial statements.

Summary of significant accounting policies

The Company’s significant accounting policies are described in Note 1, “Description of Business and Summary of Significant Accounting Policies,” to the consolidated financial statements included in the Company’s Form 10-K for the year ended April 29, 2023. There have been no material changes to the significant accounting policies in the six months ended October 28, 2023.

XML

Revenue

6 Months Ended

Oct. 28, 2023

Revenue from Contract with Customer [Abstract]

Revenue

Note 2. Revenue

The Company generates revenue from manufacturing products for customers in diversified global markets. The substantial majority of the Company’s revenue is recognized at a point in time. The Company has determined that the most definitive demonstration that control has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer location but retains ownership and control of such product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer’s usage.

Revenue associated with products which the Company believes have no alternative use (such as highly customized parts), and where the Company has an enforceable right to payment, are recognized on an over time basis. Revenue is recognized based on progress to date, which is typically even over the production process through transfer of control to the customer.

From time to time, customers may negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.

Across all products, the amount of revenue recognized corresponds to the related purchase order and is adjusted for variable consideration (such as discounts) and ongoing price adjustments. Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.

The Company’s performance obligations are typically short-term in nature. As a result, the Company has elected the practical expedient that provides an exemption from the disclosure requirements regarding information about remaining performance obligations on contracts that have original expected durations of one year or less.

Contract balances

A contract asset is an entity’s right to consideration in exchange for goods or services that the entity has transferred to a customer. A contract liability exists when an entity has received consideration, or the amount is due from the customer in advance of revenue recognition. The net changes in the contract asset and contract liability balances for the six months ended October 28, 2023 and October 29, 2022 were not material.

Disaggregated revenue information

The following table represents a disaggregation of revenue from contracts with customers by segment and geographical location. Net sales are attributed to regions based on the location of production. Though revenue recognition patterns and contracts are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.

	Three Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	70.9	$	52.0	$	11.7	$	1.5	$	136.1
Europe, the Middle East & Africa ("EMEA")		49.7		42.8		—		—		92.5
Asia		33.7		25.6		—		0.1		59.4
Total net sales	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0
Timing of revenue recognition:
Goods transferred at a point in time	$	149.9	$	120.4	$	11.7	$	1.6	$	283.6
Goods transferred over time		4.4		—		—		—		4.4
Total net sales	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0

	Three Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	97.8	$	40.1	$	14.0	$	1.1	$	153.0
EMEA		53.9		37.9		—		—		91.8
Asia		45.2		25.8		0.1		—		71.1
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9
Timing of revenue recognition:
Goods transferred at a point in time	$	192.3	$	103.8	$	14.1	$	1.1	$	311.3
Goods transferred over time		4.6		—		—		—		4.6
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9

	Six Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	137.7	$	92.0	$	26.9	$	2.3	$	258.9
EMEA		101.9		93.9		—		—		195.8
Asia		73.0		49.9		—		0.1		123.0
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7
Timing of revenue recognition:
Goods transferred at a point in time	$	304.1	$	235.8	$	26.9	$	2.4	$	569.2
Goods transferred over time		8.5		—		—		—		8.5
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7

	Six Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	192.5	$	80.8	$	27.0	$	1.8	$	302.1
EMEA		106.0		66.4		—		—		172.4
Asia		75.0		48.7		0.1		—		123.8
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3
Timing of revenue recognition:
Goods transferred at a point in time	$	364.4	$	195.9	$	27.1	$	1.8	$	589.2
Goods transferred over time		9.1		—		—		—		9.1
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3

XML

Acquisition and Disposition

6 Months Ended

Oct. 28, 2023

Acquisitions and Dispositions Disclosure [Abstract]

Acquisition and Disposition

Note 3. Acquisition and Disposition

Acquisition

On April 20, 2023, the Company acquired 92.2% of the outstanding shares in Nordic Lights Group Corporation (“Nordic Lights”), a premium provider of high-quality lighting solutions for heavy duty equipment headquartered in Finland, for €121.8 million ($134.2 million) in cash. Between May 2023 and July 2023, the Company acquired an additional 7.2% of the outstanding shares of Nordic Lights for €9.2 million ($10.2 million), increasing the Company’s ownership to 99.4%. On October 10, 2023, the Company acquired the remaining 0.6% of the outstanding shares in Nordic Lights for €0.8 million ($0.9 million), as determined by the Finnish arbitral tribunal administering the redemption proceedings for the shares not tendered to the Company. Accordingly, the Company owned 100% of the outstanding shares in Nordic Lights as of October 10, 2023. The acquisition of Nordic Lights complements the Company’s existing LED lighting solution offerings.

The acquisition was funded through a combination of borrowings under the Company's revolving credit facility and cash on hand. The results of the operations of Nordic Lights are reported within the Industrial segment from the date of acquisition. The acquisition was accounted for as a business combination. The Company has estimated the preliminary fair value of net assets acquired based on information currently available and will continue to adjust those estimates as additional information becomes available, including the refinement of valuation assumptions. As the Company finalizes the fair value of assets acquired and liabilities assumed, additional purchase price allocation adjustments will be recorded during the measurement period, but no later than one year from the date of the acquisition. The Company will reflect measurement period adjustments in the period in which the adjustments are determined. Measurement period adjustments recognized in the three months ended October 28, 2023, resulted from the receipt of incremental data utilized in the determination of fair value, including valuation assumptions.

The preliminary fair value and subsequent measurement period adjustments of the assets acquired and liabilities assumed, including a reconciliation to the total purchase price, were as follows:

	As reported as of July 29, 2023			Measurement period adjustments			As of October 28, 2023
(in millions)
Cash and cash equivalents	$	19.6		$	—		$	19.6
Accounts receivable		17.1			—			17.1
Inventories		9.6			(0.2	)		9.4
Property, plant and equipment		12.9			3.4			16.3
Identifiable intangible assets		68.1			24.5			92.6
Accounts payable		(10.8	)		—			(10.8	)
Long-term debt		(24.4	)		—			(24.4	)
Other assets and liabilities, net		(2.8	)		(0.5	)		(3.3	)
Deferred tax liabilities		(13.4	)		(5.4	)		(18.8	)
Total identifiable net assets acquired		75.9			21.8			97.7
Goodwill		69.6			(21.8	)		47.8
Total fair value of net assets acquired		145.5			—			145.5
Less: redeemable noncontrolling interest		(11.3	)		—			(11.3	)
Total purchase price	$	134.2		$	—		$	134.2

The noncontrolling interest was recognized at fair value, which was determined to be the noncontrolling interest’s proportionate share of the fair value of net assets acquired, as of the acquisition date. The noncontrolling interest is classified as a redeemable noncontrolling interest on the condensed consolidated balance sheets as minority shareholders owning less than 10% of the outstanding shares in a company in Finland have the right to require the company to redeem their shares. As noted above, in the six months ended October 28, 2023, the Company acquired the entire redeemable noncontrolling interest.

Goodwill arising from the acquisition was included in the Industrial segment as of October 28, 2023 and was attributable to potential synergies and an assembled workforce. The Company does not expect any recognized goodwill from this acquisition to be deductible for income tax purposes.

Intangible assets primarily include customer relationships, technology licenses and trademarks. The weighted average amortization period for the acquired intangible assets is approximately 18.2 years.

The pro-forma effects of this acquisition would not materially impact the Company’s operating results for the six months ended October 29, 2022, and as a result no pro-forma financial statements are presented. In the six months ended October 28, 2023, additional acquisition costs of $0.5 million were incurred and reported in selling and administrative expenses.

Disposition

In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of the Dabir business in the Medical segment. On October 13, 2023, the Company sold certain assets and contracts of its Dabir business to a third party for consideration of $1.5 million. In the three and six months ended October 28, 2023, the Company recorded a loss on the sale, including transaction costs, of $0.6 million, which was included in other income, net on the Company's condensed consolidated statement of operations. The discontinuation of the Dabir business does not qualify as a discontinued operation as it does not represent a strategic shift that would have a major effect on the Company's operations or financial results.

XML

Income Taxes

6 Months Ended

Oct. 28, 2023

Income Tax Disclosure [Abstract]

Income Taxes

Note 4. Income Taxes

The provision for income taxes for an interim period is based on an estimated annual effective income tax rate applied to ordinary year-to-date earnings or losses. The estimated annual effective income tax rate is determined excluding the effects of unusual or significant one-time items that are reported net of the related tax effects in the period in which they occur. In addition, any material effects of enacted tax law or rate changes as well as the Company’s ability to utilize various tax assets is recognized in the period in which the change occurs.

The computation of the estimated annual effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year by jurisdiction, certain book to tax adjustments, and the likelihood of the realizability of deferred tax assets generated in the current year. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as the Company’s tax environment changes.

The Company’s income tax (benefit) expense and effective tax rate for the three and six months ended October 28, 2023 and October 29, 2022 were as follows:

	Three Months Ended						Six Months Ended
($ in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Pre-tax (loss) income	$	(55.5	)	$	33.4		$	(54.5	)	$	59.3
Income tax (benefit) expense	$	(0.2	)		5.8		$	(0.1	)		10.2
Effective tax rate		0.4	%		17.4	%		0.2	%		17.2	%

The effective tax rate for the three and six months ended October 28, 2023 was lower than the U.S. federal statutory tax rate of 21% primarily due to the impact of an impairment of goodwill which is non-deductible for tax purposes, income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, offset by global intangible low-tax income. The effective tax rate for the three and six months ended October 29, 2022 was lower than the U.S. federal statutory tax rate of 21% primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses.

The Company’s gross unrecognized income tax benefits were $4.6 million and $4.5 million as of October 28, 2023 and April 29, 2023, respectively. If any portion of the Company’s unrecognized tax benefits is recognized, it would impact the Company’s effective tax rate. The unrecognized tax benefits are reviewed periodically and adjusted for changing facts and circumstances, such as tax audits, the lapsing of applicable statutes of limitations and changes in tax law. The Company recognizes interest and penalties related to income tax uncertainties in income tax expense. Accrued interest and penalties were $0.3 million and $0.2 million as of October 28, 2023 and April 29, 2023, respectively.

XML

Balance Sheet Components

6 Months Ended

Oct. 28, 2023

Balance Sheet Components [Abstract]

Balance Sheet Components

Note 5. Balance Sheet Components

Cash and cash equivalents

Cash and cash equivalents consist of cash and highly liquid investments with maturities of three months or less. Highly liquid investments include money market funds which are classified within Level 1 of the fair value hierarchy. As of October 28, 2023 and April 29, 2023, the Company had a balance of $0.2 million and $1.3 million, respectively, in money market accounts.

Accounts receivable and allowance for doubtful accounts

Accounts receivable are customer obligations due under normal trade terms and are presented net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on the current expected credit loss impairment model. The Company applies a historical loss rate based on historic write-offs to aging categories. The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. The Company may also record a specific reserve for individual accounts when it becomes aware of specific customer circumstances, such as in the case of a bankruptcy filing or deterioration in the customer’s operating results or financial position. The allowance for doubtful accounts balance was $1.5 million and $1.3 million at October 28, 2023 and April 29, 2023, respectively.

Inventories

Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand. A summary of inventories is shown below:

(in millions)	October 28, 2023		April 29, 2023
Finished products	$	47.3	$	36.6
Work in process		17.7		14.4
Raw materials		118.9		108.7
Total inventories	$	183.9	$	159.7

Property, plant and equipment

Property, plant and equipment is stated at cost. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method using estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment. A summary of property, plant and equipment is shown below:

(in millions)	October 28, 2023			April 29, 2023
Land	$	3.0		$	3.0
Buildings and building improvements		99.5			98.8
Machinery and equipment		411.4			414.3
Construction in progress		48.0			40.6
Total property, plant and equipment, gross		561.9			556.7
Less: accumulated depreciation		(337.3	)		(336.4	)
Property, plant and equipment, net	$	224.6		$	220.3

Depreciation expense was $8.2 million and $7.5 million in the three months ended October 28, 2023 and October 29, 2022, respectively. Depreciation expense was $16.5 million and $15.1 million in the six months ended October 28, 2023 and October 29, 2022, respectively. As of October 28, 2023 and April 29, 2023, capital expenditures recorded in accounts payable totaled $5.6 million and $4.5 million, respectively.

Pre-production tooling costs related to long-term supply arrangements

The Company incurs pre-production tooling costs related to products produced for its customers under long-term supply arrangements. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred, unless the costs are reimbursable by the customer. As of October 28, 2023 and April 29, 2023, the Company had $44.5 million and $36.1 million, respectively, of pre-production tooling costs related to customer-owned tools for which reimbursement is contractually guaranteed by the customer or for which the customer has provided a non-cancelable right to use the tooling.

Costs for molds, dies and other tools used in products produced for its customers under long-term supply arrangements for which the Company has title are capitalized in property, plant and equipment and amortized over the shorter of the life of the arrangement or the estimated useful life of the assets. As of October 28, 2023 and April 29, 2023, Company-owned tooling was $15.6 million and $12.2 million, respectively.

XML

Goodwill and Other Intangible Assets

6 Months Ended

Oct. 28, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

Note 6. Goodwill and Other Intangible Assets

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. A summary of the changes in the carrying amount of goodwill, by segment, is shown below:

(in millions)	Automotive			Industrial			Total
Balance as of April 29, 2023	$	106.2		$	195.7		$	301.9
Acquisition (Note 3)		—			(21.8	)		(21.8	)
Impairment		(56.5	)		—			(56.5	)
Foreign currency translation		(0.3	)		(2.6	)		(2.9	)
Balance as of October 28, 2023	$	49.4		$	171.3		$	220.7

The Company tests goodwill and indefinite-lived intangible assets for impairment on an annual basis as of the beginning of the fourth quarter each fiscal year. In addition, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore require interim goodwill impairment testing, including long-term revenue growth projections, profitability, discount rates, volatility in the Company's market capitalization, and general industry, market and macroeconomic conditions.

As a result of sustained decreases in the Company’s publicly quoted share price, market capitalization and lower than expected operating results, the Company concluded that a triggering event had occurred requiring an interim goodwill impairment assessment. These factors suggested that the fair value of one or more of the Company's reporting units may have fallen below their carrying amounts. The Company quantitatively assessed its reporting units which have performed substantially below the forecast used in its last quantitative fair value test. The reporting units that were quantitatively assessed were North American Automotive ("NAA") and European Automotive ("EA").

The Company engaged a third-party valuation specialist to assist management in performing the interim goodwill impairment assessment. The fair value of the NAA and EA reporting units were estimated using a combination of the income approach and market approach, weighted accordingly for the specific circumstances of the reporting unit. The income approach uses a discounted cash flow method and the market approach uses appropriate valuation multiples observed for the reporting unit’s guideline public companies. The determination of discounted cash flows are based on management’s estimates of revenue growth rates and earnings before interest, taxes, depreciation and amortization (“EBITDA”) margins, taking into consideration business and market conditions for the countries and markets in which the reporting unit operates. The Company calculates the discount rate based on a market-participant, risk-adjusted weighted average cost of capital, which considers industry specific rates of return on debt and equity capital for a target industry capital structure, adjusted for risks associated with business size, geography and other factors specific to the reporting unit. Long-range forecasting involves uncertainty which increases with each successive period. Revenue growth rates and profitability assumptions, especially in the outer years, involve a greater degree of uncertainty.

Based upon the results of the quantitative impairment test, the Company determined the carrying value of the NAA and EA reporting units exceeded their fair value at October 28, 2023. As a result, the Company recognized a non-cash goodwill impairment charge of $56.5 million ($50.4 million for NAA and $6.1 million for EA, respectively) in the three and six months ended October 28, 2023, which was determined as the excess carrying value over fair value of the respective reporting unit up to the carrying value of the goodwill immediately prior to the impairment. Any significant changes to the assumptions regarding future performance, an adverse change to macroeconomic conditions, a further reduction in the Company's market capitalization, or a change to other assumptions could result in impairment losses in the future, which could be significant.

A summary of goodwill by reporting unit is as follows:

(in millions)	October 28, 2023		April 29, 2023
Grakon Industrial	$	123.9	$	124.5
North American Automotive		49.4		99.8
Nordic Lights		45.8		69.6
European Automotive		—		6.4
Other		1.6		1.6
Total	$	220.7	$	301.9

Other intangible assets, net

Details of identifiable intangible assets are shown below:

	As of October 28, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	303.6	$	(76.1	)	$	227.5		15.2
Trade names, patents and technology licenses		74.0		(38.6	)		35.4		7.1
Total amortized intangible assets		377.6		(114.7	)		262.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	379.4	$	(114.7	)	$	264.7

	As of April 29, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	286.7	$	(68.2	)	$	218.5		14.8
Trade names, patents and technology licenses		71.6		(35.2	)		36.4		6.0
Total amortized intangible assets		358.3		(103.4	)		254.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	360.1	$	(103.4	)	$	256.7

Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:

(in millions)
Fiscal Year:
Remainder of 2024	$	11.8
2025		23.1
2026		22.2
2027		21.6
2028		19.3
Thereafter		164.9
Total	$	262.9

XML

Derivative Instruments and Hedging Activities

6 Months Ended

Oct. 28, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

Note 7. Derivative Instruments and Hedging Activities

The Company is exposed to various market risks including, but not limited to, foreign currency exchange rates and market interest rates. The Company strives to control its exposure to these risks through our normal operating activities and, where appropriate, through the use of derivative financial instruments. Derivative financial instruments are measured at fair value on a recurring basis.

For a designated cash flow hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded in accumulated other comprehensive income (“AOCI”) in the condensed consolidated balance sheets. When the underlying hedged transaction is realized, the gain or loss previously included in AOCI is recorded in earnings and reflected in the condensed consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. The gain or loss associated with changes in the fair value of derivatives not designated as hedges are recorded immediately in the condensed consolidated statements of income on the same line as the associated risk. For a designated net investment hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded as a cumulative translation adjustment in AOCI in the condensed consolidated balance sheets.

Net investment hedges

The Company is exposed to the risk that adverse changes in foreign currency exchange rates could impact its net investment in non-U.S. subsidiaries. To manage this risk, the Company designates certain qualifying derivative and non-derivative instruments, including cross-currency swaps and foreign currency-denominated debt, as net investment hedges of certain non-U.S. subsidiaries.

The Company had a variable-rate, cross-currency swap, with a notional value of $60.0 million (€54.8 million), that matured on August 31, 2023 with a gain of approximately $0.6 million. The cross-currency swap was designated as a hedge of the Company’s net investment in its euro-denominated subsidiaries. The gain will remain in AOCI until the hedged net investment is sold or substantially liquidated.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter, under the spot-to-spot method. The Company recognizes the impact of all other changes in fair value of the derivative, which represents the interest rate differential of the cross-currency swap, through interest expense. For the three months ended October 28, 2023 and October 29, 2022, the Company recorded gains of $0.4 million and $0.6 million, respectively, in interest expense, net in the condensed consolidated statements of income. For the six months ended October 28, 2023 and October 29, 2022, the Company recorded gains of $1.1 million and $0.9 million, respectively, in interest expense, net in the condensed consolidated statements of income.

The Company has also designated its euro-denominated long-term borrowings of $290.6 million under the Credit Agreement as a hedge of the Company's investment in its euro-denominated subsidiaries. The objective of the designation is to protect the net investment in the foreign operation against adverse changes in the euro exchange rate. The change in the value of the euro-denominated long-term borrowings, which is due to changes in foreign exchange rates, is recorded as a cumulative translation adjustment in AOCI, net of tax. For the three months ended October 28, 2023, the transaction gain associated with this net investment hedge reported in AOCI was $7.5 million. For the six months ended October 28, 2023 the transaction gain associated with this net investment hedge reported in AOCI was $7.3 million.

Interest rate swaps

The Company utilizes interest rate swaps to limit its exposure to market fluctuations on its variable-rate borrowings. The interest rate swaps effectively convert a portion of the Company's variable rate borrowings to a fixed rate based upon a determined notional amount. The Company has an interest rate swap, maturing on October 31, 2027, with a notional value of $145.5 million (€132.0 million) and had two interest rate swaps that matured on August 31, 2023, with a notional value of $100.0 million. The interest rate swaps are designated as cash flow hedges.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter. The effective portion of the periodic changes in fair value is recognized in AOCI in the condensed consolidated balance sheets. Subsequently, the accumulated gains and losses recorded in AOCI are reclassified to income in the period during which the hedged cash flow impacts earnings, which are expected to be immaterial over the next 12 months. No ineffectiveness was recognized in the three or six months ended October 28, 2023 and October 29, 2022.

Derivatives not designated as hedges

The Company uses short-term foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. These forward contracts are not designated as hedging instruments. Gains and losses on these forward contracts are recognized in other income, net, along with the foreign currency gains and losses on monetary assets and liabilities, in the condensed consolidated statements of income.

As of October 28, 2023 and April 29, 2023, the Company held foreign currency forward contracts with a notional value of $71.9 million and $59.9 million, respectively. During the three and six months ended October 28, 2023, the Company recognized a loss of $0.8 million and $2.7 million, respectively, related to foreign currency forward contracts in the condensed consolidated statements of income. During the three and six months ended October 29, 2022, the Company recognized a loss of $2.4 million and $2.8 million, respectively, related to foreign currency forward contracts in the condensed consolidated statements of income.

Fair value of derivative instruments on the balance sheet

The fair value of derivative instruments are classified as Level 2 within the fair value hierarchy and are recorded in the balance sheets as follows:

		Asset/(Liability)
(in millions)	Financial Statement Caption	October 28, 2023			April 29, 2023
Derivatives designated as hedging instruments:
Net investment hedges	Other accrued liabilities	$	—		$	(0.5	)
Interest rate swaps	Prepaid expenses and other current assets	$	—		$	1.6
Interest rate swaps	Other long-term liabilities	$	(1.1	)	$	—
Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	—		$	0.1
Foreign currency forward contracts	Other accrued liabilities	$	(0.1	)	$	(0.1	)

Effect of derivative instruments on comprehensive income (loss)

Gross amounts recorded in other comprehensive income (loss) were as follows:

	Three Months Ended					Six Months Ended
(in millions)	October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Net investment hedges	$	1.1		$	1.4	$	1.2		$	3.4
Interest rate swaps		(0.4	)		0.7		(2.7	)		0.7
Total	$	0.7		$	2.1	$	(1.5	)	$	4.1

XML

Debt

6 Months Ended

Oct. 28, 2023

Debt Disclosure [Abstract]

Debt

Note 8. Debt

A summary of debt is shown below:

(in millions)	October 28, 2023			April 29, 2023
Revolving credit facility	$	330.6		$	305.4
Other debt		4.4			4.7
Unamortized debt issuance costs		(3.0	)		(3.3	)
Total debt		332.0			306.8
Less: current maturities		(3.0	)		(3.2	)
Total long-term debt	$	329.0		$	303.6

Revolving credit facility/term loan

On October 31, 2022, the Company entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amends and restates the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750,000,000, (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement. In addition, the Credit Agreement permits the Company to increase the revolving commitments and/or add one or more tranches of term loans under the Credit Agreement from time to time by up to an amount equal to (i) $250,000,000 plus (ii) an additional amount so long as the leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Credit Agreement matures on October 31, 2027.

Loans denominated in US dollars under the Credit Agreement bear interest at either (a) an adjusted base rate or (b) an adjusted term Secured Overnight Financing Rate (“SOFR”) rate or term SOFR daily floating rate (in each case, as determined in accordance with the provisions of the Credit Agreement) in each case plus an applicable rate (the “Applicable Rate”) ranging between 0.375% and 1.25%, in the case of adjusted base rate loans, and between 1.375% and 2.25%, in the case of adjusted term SOFR rate loans and term SOFR daily floating rate loans. Loans denominated in euros will bear interest at the Euro Interbank Offered Rate plus an Applicable Rate ranging between 1.375% and 2.25%. The Applicable Rate is set based on the Company’s consolidated leverage ratio.

As of October 28, 2023, the outstanding balance under the revolving credit facility included $290.6 million (€275.0 million) of euro-denominated borrowings. The Company has designated the euro-denominated borrowings as a net investment hedge of the foreign currency exposure of its investments in euro-denominated subsidiaries. Refer to Note 7, "Derivative Financial Instruments and Hedging Activities" for further information.

The weighted-average interest rate on outstanding US dollar and euro-denominated borrowings under the Credit Agreement was approximately 7.2% and 5.6%, respectively, as of October 28, 2023. The Credit Agreement contains customary representations and warranties, financial covenants, restrictive covenants and events of default. As of October 28, 2023, the Company was in compliance with all the covenants in the Credit Agreement.

Other debt

One of the Company’s European subsidiaries has debt that consists of three notes with maturities ranging from 2023 to 2031. The weighted-average interest rate on this debt was approximately 1.4% at October 28, 2023 and $3.0 million of the debt was classified as short-term.

XML

Shareholders' Equity

6 Months Ended

Oct. 28, 2023

Share-Based Payment Arrangement [Abstract]

Shareholders' Equity

Note 9. Shareholders’ Equity

Share buyback program

The Board of Directors authorized a program to purchase up to $200.0 million of the Company’s outstanding common stock through June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

The following table summarizes the Company’s stock buyback activity under this share buyback program:

	Three Months Ended				Six Months Ended
(in millions, except share and per share data)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Shares purchased		322,779		508,179		322,779		825,814
Average price per share	$	24.03	$	38.69	$	24.03	$	38.21
Total cost	$	7.8	$	19.7	$	7.8	31.6

As of October 28, 2023, a total of 3,113,154 shares have been purchased at a total cost of $127.1 million since the commencement of the share buyback program. All purchased shares were retired and are reflected as a reduction of common stock for the par value of shares, with the excess applied as a reduction to retained earnings. As of October 28, 2023, the dollar value of shares that remained available to be purchased by the Company under this share buyback program was $72.9 million.

Dividends

The Company paid dividends totaling $4.8 million and $4.9 million in the three months ended October 28, 2023 and October 29, 2022, respectively. The Company paid dividends totaling $10.1 million and $9.9 million in the six months ended October 28, 2023 and October 29, 2022, respectively. Dividends paid in the six months ended October 28, 2023 include $0.4 million of dividend equivalent payments for restricted stock units that vested at the end of fiscal 2023.

Accumulated other comprehensive income (loss)

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in AOCI, net of tax is shown below:

	Three Months Ended October 28, 2023									Six Months Ended October 28, 2023
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(22.3	)	$	(0.8	)	$	(23.1	)	$	(19.8	)	$	0.8		$	(19.0	)
Other comprehensive income (loss)		(17.6	)		0.7			(16.9	)		(20.3	)		(1.5	)		(21.8	)
Tax (expense) benefit		(2.6	)		(0.3	)		(2.9	)		(2.4	)		0.3			(2.1	)
Net other comprehensive income (loss)		(20.2	)		0.4			(19.8	)		(22.7	)		(1.2	)		(23.9	)
Balance at the end of period	$	(42.5	)	$	(0.4	)	$	(42.9	)	$	(42.5	)	$	(0.4	)	$	(42.9	)

	Three Months Ended October 29, 2022									Six Months Ended October 29, 2022
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(41.4	)	$	5.2		$	(36.2	)	$	(30.5	)	$	3.7		$	(26.8	)
Other comprehensive income (loss)		(19.9	)		2.1			(17.8	)		(30.8	)		4.1			(26.7	)
Tax (expense) benefit		0.2			(0.5	)		(0.3	)		0.2			(1.0	)		(0.8	)
Net other comprehensive income (loss)		(19.7	)		1.6			(18.1	)		(30.6	)		3.1			(27.5	)
Balance at the end of period	$	(61.1	)	$	6.8		$	(54.3	)	$	(61.1	)	$	6.8		$	(54.3	)

Stock-based compensation

The Company has granted stock options, restricted stock awards (“RSAs”), performance units (“PUs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under the Methode Electronics, Inc. 2022 Omnibus Incentive Plan (“2022 Plan”), the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”), the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company’s stockholders approved the 2022 Plan on September 14, 2022. The Company can no longer make grants under the 2014 Plan, 2010 Plan and 2004 Plan.

Subject to adjustment as provided in the 2022 Plan and the 2022 Plan’s share counting provisions, the number of shares of the Company's common stock that will be available for all awards under the 2022 Plan is 5,550,000, less one share for every one share of common stock subject to an option or SAR award granted after April 30, 2022 under the 2014 Plan and 2.28 shares for every one share that was subject to an award other than an option or SAR granted after April 30, 2022 under the 2014 Plan. As of October 28, 2023, there were 4,943,780 shares available for award under the 2022 Plan.

Restricted stock awards and performance units

As of October 28, 2023, the Company had 933,674 RSAs outstanding which may be earned based on the achievement of an earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) measure for fiscal 2025. The RSAs will vest ranging from 0% (for performance below threshold) to 100% (target performance) based on the achievement of the EBITDA performance measure and continued employment. In addition, if the target performance is exceeded, up to an additional 466,837 PUs can be earned that will be settled in cash. At the discretion of the Compensation Committee, the PUs may be settled in shares of common stock.

The fair value of the RSAs was based on the closing stock price on the date of grant and the RSAs earn dividend equivalents during the vesting period, which are forfeitable if the RSAs do not vest. Compensation expense for the RSAs is recognized when it is probable the minimum threshold performance criteria will be achieved. Compensation expense for the PUs is recognized when it is probable that the target performance criteria will be exceeded. The Company assesses the probability of vesting at each balance sheet date and adjusts compensation costs based on the probability assessment. The cash-settled PUs represent a non-equity unit with a conversion value equal to the fair market value of a share of the Company’s common stock on the vesting date. The PUs are classified as liability awards due to the cash settlement feature and are re-measured at each balance sheet date. In accordance with ASC 718, based on projections of the Company’s current business portfolio, no compensation expense has been recognized for the RSAs or PUs to date, as the performance conditions are not probable of being met. Unrecognized stock-based compensation expense at target level of performance is $26.8 million as of October 28, 2023, which, subject to the performance conditions being met, will be recognized through fiscal 2025. The following table summarizes RSA activity:

	Restricted stock awards		Weighted average grant date fair value
Non-vested at April 29, 2023		933,674	$	28.73
Awarded		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Non-vested at October 28, 2023		933,674	$	28.73

Restricted stock units

RSUs granted vest over a pre-determined period of time, up to five years from the date of grant. The fair value of the RSUs granted are based on the closing stock price on the date of grant and earn dividend equivalents during the vesting periods, which are forfeitable if the RSUs don’t vest. The following table summarizes RSU activity:

	Restricted stock units			Weighted average grant date fair value
Non-vested at April 29, 2023		727,467		$	30.60
Awarded		207,050		$	22.83
Vested		(866	)	$	38.24
Forfeited		(13,474	)	$	41.62
Non-vested at October 28, 2023		920,177		$	28.68

Under the various stock plans, common stock underlying vested RSUs held by certain executives will not be delivered until termination of employment or a change of control of the Company. As of October 28, 2023, common stock to be delivered to these executives totaled 577,055 shares.

Director awards

The Company grants stock awards to its non-employee directors as a component of their compensation. The stock awards vest immediately upon grant. Non-employee directors may elect to defer receipt of their shares under the Company’s non-qualified deferred compensation plan. The following table summarizes awards granted to non-employee directors:

	Non-employee director awards			Deferred non-employee director awards		Total			Weighted average grant date fair value
Outstanding at April 29, 2023		—			45,750		45,750		$	40.56
Awarded		16,804			30,194		46,998		$	33.22
Issued		(16,804	)		—		(16,804	)	$	33.32
Outstanding at October 28, 2023		—			75,944		75,944		$	37.62

Stock options

The following table summarizes stock option activity:

	Stock options		Weighted average exercise price		Weighted- average life (years)		Aggregate intrinsic value (in millions)
Outstanding and exercisable at April 29, 2023		20,000	$	37.01		1.2	$	0.1
Exercised		—	$	—
Forfeited		—	$	—
Outstanding and exercisable at October 28, 2023		20,000	$	37.01		0.7	$	0.0

The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on that date.

Stock-based compensation expense

All stock-based awards to employees and non-employee directors are recognized in selling and administrative expenses on the condensed consolidated statements of income. Awards subject to graded vesting are recognized using the accelerated recognition method over the requisite service period. The table below summarizes the stock-based compensation expense related to the equity awards:

	Three Months Ended				Six Months Ended
(in millions)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
RSUs	$	1.3	$	2.7	$	2.3	$	5.1
Deferred non-employee director awards		—		—		1.0		1.0
Non-employee director awards		—		—		0.6		0.6
Total stock-based compensation expense	$	1.3	$	2.7	$	3.9	$	6.7

XML

(Loss) Income per Share

6 Months Ended

Oct. 28, 2023

Earnings Per Share [Abstract]

(Loss) Income per Share

Note 10. (Loss) Income per Share

Basic (loss) income per share attributable to Methode is calculated by dividing net (loss) income attributable to Methode by the weighted average number of common shares outstanding for the applicable period, but excludes any contingently issued shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted (loss) income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.

The following table sets forth the computation of basic and diluted (loss) income per share attributable to Methode:

	Three Months Ended					Six Months Ended
	October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Numerator:
Net (loss) income attributable to Methode (in millions)	$	(55.3	)	$	27.6	$	(54.4	)	$	49.1
Denominator:
Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units		35,671,677			36,126,132		35,679,776			36,346,054
Dilutive potential common shares		—			715,699		—			682,762
Denominator for diluted income per share		35,671,677			36,841,831		35,679,776			37,028,816
(Loss) income per share attributable to Methode:
Basic	$	(1.55	)	$	0.76	$	(1.52	)	$	1.35
Diluted	$	(1.55	)	$	0.75	$	(1.52	)	$	1.33
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding		1,543,183			940,510		1,536,206			934,522

In the three and six months ended October 28, 2023, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 584,000 and 589,000 common shares for the three and six months ended October 28, 2023, respectively.

XML

Segment Information

6 Months Ended

Oct. 28, 2023

Segment Reporting [Abstract]

Segment Information

Note 11. Segment Information

An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenues and incur expenses, and about which separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. The CODM is the Company’s President and Chief Executive Officer. The Company has four reporting segments as described below.

The Automotive segment supplies electronic and electro-mechanical devices and related products to automobile OEMs, either directly or through their tiered suppliers. Products include integrated center consoles, hidden switches, ergonomic switches, transmission lead-frames, LED-based lighting and sensors, which incorporate magneto-elastic sensing and other technologies that monitor the operation or status of a component or system.

The Industrial segment manufactures external lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices, custom power-product assemblies, such as our PowerRail® solution, high-current low-voltage flexible power cabling systems and powder-coated busbars that are used in various markets and applications, including aerospace, computers, industrial, power conversion, military, telecommunications and transportation.

The Interface segment provides a variety of copper and fiber-optic interface and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale and telecommunications markets. Solutions include copper transceivers and solid-state field-effect consumer touch panels.

The Medical segment is made up of the Company’s medical device business, Dabir Surfaces, with its surface support technology aimed at pressure injury prevention. Methode developed the technology for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures. In the first quarter of fiscal 2024, the Company made the decision to initiate the discontinuation of Dabir Surfaces. In October 2023, the Company sold certain assets of its Dabir Surfaces business. See Note 3, "Acquisition and Disposition" for more information.

The tables below present information about the Company’s reportable segments:

	Three Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations/ Corporate			Consolidated
Net sales	$	158.0		$	128.0		$	11.7	$	1.6		$	(11.3	)	$	288.0
Transfers between segments		(3.7	)		(7.6	)		—		—			11.3			—
Net sales to unaffiliated customers	$	154.3		$	120.4		$	11.7	$	1.6		$	—		$	288.0
Income (loss) from operations	$	(61.5	)	$	25.7		$	1.0	$	(0.7	)	$	(15.8	)	$	(51.3	)
Interest expense, net																4.4
Other income, net																(0.2	)
Pre-tax loss															$	(55.5	)
Goodwill impairment	$	56.5		$	—		$	—	$	—		$	—		$	56.5

	Three Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	198.3		$	107.8		$	14.1	$	1.1		$	(5.4	)	$	315.9
Transfers between segments		(1.4	)		(4.0	)		—		—			5.4			—
Net sales to unaffiliated customers	$	196.9		$	103.8		$	14.1	$	1.1		$	—		$	315.9
Income (loss) from operations	$	23.4		$	25.0		$	1.6	$	(1.4	)	$	(15.8	)	$	32.8
Interest expense, net																0.5
Other income, net																(1.1	)
Pre-tax income															$	33.4

	Six Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface			Medical			Eliminations/ Corporate			Consolidated
Net sales	$	319.1		$	250.6		$	27.0		$	2.4		$	(21.4	)	$	577.7
Transfers between segments		(6.5	)		(14.8	)		(0.1	)		—			21.4			—
Net sales to unaffiliated customers	$	312.6		$	235.8		$	26.9		$	2.4		$	—		$	577.7
Income (loss) from operations	$	(64.3	)	$	49.9		$	3.9		$	(2.9	)	$	(34.1	)	$	(47.5	)
Interest expense, net																	7.2
Other income, net																	(0.2	)
Pre-tax loss																$	(54.5	)
Goodwill impairment	$	56.5		$	—		$	—		$	—		$	—		$	56.5

	Six Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	375.6		$	201.5		$	27.1	$	1.8		$	(7.7	)	$	598.3
Transfers between segments		(2.1	)		(5.6	)		—		—			7.7			—
Net sales to unaffiliated customers	$	373.5		$	195.9		$	27.1	$	1.8		$	—		$	598.3
Income (loss) from operations	$	38.1		$	47.4		$	3.2	$	(2.9	)	$	(31.2	)	$	54.6
Interest expense, net																0.5
Other income, net																(5.2	)
Pre-tax income															$	59.3

(in millions)	October 28, 2023		April 29, 2023
Identifiable assets:
Automotive	$	643.3	$	700.2
Industrial		636.8		672.3
Interface		117.5		127.2
Medical		0.8		6.2
Eliminations/Corporate		86.5		73.2
Total identifiable assets	$	1,484.9	$	1,579.1

XML

Contingencies

6 Months Ended

Oct. 28, 2023

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Note 12. Contingencies

Certain litigation arising in the normal course of business is pending against us. The Company is, from time-to-time, subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, employment-related matters, environmental matters and intellectual property matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the Company's opinion, based on the information available, that it has adequate reserves for these liabilities.

Hetronic Germany-GmbH Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. The Company became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, the Company terminated all of its agreements with the Fuchs companies. On June 20, 2014, the Company filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, the Company amended its complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties have filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. The Company opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court heard arguments in this matter on March 21, 2023. On June 29, 2023, the Supreme Court vacated the Tenth Circuit’s August 2021 decision and remanded the matter back to the Tenth Circuit for further proceedings. On September 1, 2023, the Tenth Circuit requested supplemental briefing from the parties regarding the effect of the Supreme Court’s decision on the appeal and the proper course of further proceedings. That briefing was thereafter submitted.

Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that the Company will be able to collect all or any portion of the judgment. Furthermore, defendants Abitron Germany and Hetronic Germany filed for insolvency in German court in September and October 2023 respectively, and the Germany insolvency court then appointed a receiver. These insolvency proceedings could potentially adversely impact our ability to enforce or collect upon the judgment or portions of the judgment or otherwise pursue or enforce claims or rights against those defendants.

XML

Restructuring

6 Months Ended

Oct. 28, 2023

Restructuring and Related Activities [Abstract]

Restructuring

Note 13. Restructuring

The Company continually monitors market factors and industry trends and takes restructuring actions to reduce overall costs and improve operational profitability as appropriate. Restructuring actions generally result in charges for employee termination benefits, plant closures, asset impairments and contract termination costs.

As noted above, the Company made the decision to initiate the discontinuation of the Dabir business in the Medical segment. The Company recognized $0.4 million and $0.5 million of severance costs in the three and six months ended October 28, 2023, respectively, in selling and administrative expenses. In addition, in the six months ended October 28, 2023, the Company recognized fixed asset impairment charges of $0.6 million in cost of products sold related to this restructuring action. In the Automotive segment, the Company recognized $0.2 million of severance costs in the three and six months ended October 28, 2023. In the three and six months ended October 29, 2022, restructuring costs primarily related to an impairment of an operating lease right-of-use asset.

Employee termination benefits are accrued upon the commitment to a termination plan and when the benefit arrangement is communicated to affected employees, or when liabilities are determined to be probable and estimable. Asset impairment charges relate to the impairment of right-of-use lease assets and equipment. Components of restructuring costs were as follows:

	Three Months Ended				Six Months Ended
(in millions)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Automotive	$	0.2	$	—	$	0.2	$	—
Industrial		—		0.4		—		0.5
Interface		—		—		—		—
Medical		0.4		—		1.1		—
Eliminations/Corporate		—		0.1		—		0.1
Total restructuring costs	$	0.6	$	0.5	$	1.3	$	0.6
Recognized in:
Cost of products sold	$	0.2	$	0.1	$	0.8	$	0.1
Selling and administrative expenses		0.4		0.4		0.5		0.5
	$	0.6	$	0.5	$	1.3	$	0.6

The Company's restructuring liability was $0.1 million as of October 28, 2023. Estimates of restructuring costs are based on information available at the time such charges are recorded. Due to the inherent uncertainty involved in estimating restructuring costs, actual amounts paid for such activities may differ from amounts initially recorded. Accordingly, the Company may record revisions of previous estimates by adjusting previously established accruals.

XML

Subsequent Events

6 Months Ended

Oct. 28, 2023

Subsequent Events [Abstract]

Subsequent Events

Note 14. Subsequent Events

On December 5, 2023, the Board of Directors of the Company removed Joseph Khoury from his position as Chief Operating Officer of the Company, and Mr. Khoury was terminated as an employee of the Company’s Egyptian subsidiary and is no longer associated with the Company. Mr. Khoury was placed on leave from that position on July 10, 2023, as previously reported in the Company’s Current Report on Form 8-K filed on July 14, 2023. As previously disclosed, multiple other officers of the Company have assumed Mr. Khoury’s management duties during this period, while remaining in their current positions and as a result, the Company has eliminated the position of Chief Operating Officer for the present time following Mr. Khoury’s departure from Methode. As a result, the Company expects to reverse between $3.5 million and $3.9 million of previously recognized compensation expense in the third quarter of fiscal 2024.

On December 6, 2023, the Board of Directors of the Company declared a quarterly dividend of $0.14 per share to be paid on January 26, 2024, to common stockholders of record at the close of business on January 12, 2024.

XML

Description of Business and Summary of Significant Accounting Policies (Policies)

6 Months Ended

Oct. 28, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany balances and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair presentation of the results of operations, financial position and cash flows of the Company for the interim periods presented. These financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Form 10-K for the year ended April 29, 2023, filed with the SEC on June 27, 2023. Results may vary from quarter to quarter for reasons other than seasonality.

Financial Reporting Periods

Financial reporting periods

The Company maintains its financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. The three months ended October 28, 2023 and October 29, 2022 were both 13-week periods and the six months ended October 28, 2023 and October 29, 2022 were both 26-week periods.

Use of Estimates

Use of estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. These estimates and assumptions are subject to an inherent degree of uncertainty and may change, as new events occur, and additional information is obtained. As a result, actual results may differ from previously estimated amounts, and such differences may be material to the condensed consolidated financial statements.

Recently Adopted Accounting Pronouncements

Recently adopted accounting pronouncements

In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, “Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured at the acquisition date in accordance with Accounting Standards Codification ("ASC") 606, as if the acquirer had originated the contracts. Prior to the issuance of this ASU, contract assets and liabilities were recognized at fair value on the acquisition date. The Company adopted this ASU in the first quarter of fiscal 2024 on a prospective basis. The adoption of this ASU did not have a material impact on its condensed consolidated financial statements or related disclosures and is only applicable to future business acquisitions.

New accounting pronouncements not yet adopted

In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which requires public entities to disclose information about their reportable segments’ significant expenses on an interim and annual basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. Early adoption is permitted. The adoption of this ASU will result in increased disclosures for the Company's segments.

There have been no other newly issued or newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements. Further, at October 28, 2023, there are no other pronouncements pending adoption that are expected to have a material impact on the Company’s condensed consolidated financial statements.

Summary of Significant Accounting Policies

Summary of significant accounting policies

The Company’s significant accounting policies are described in Note 1, “Description of Business and Summary of Significant Accounting Policies,” to the consolidated financial statements included in the Company’s Form 10-K for the year ended April 29, 2023. There have been no material changes to the significant accounting policies in the six months ended October 28, 2023.

Revenue

From time to time, customers may negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.

Across all products, the amount of revenue recognized corresponds to the related purchase order and is adjusted for variable consideration (such as discounts) and ongoing price adjustments. Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.

The Company’s performance obligations are typically short-term in nature. As a result, the Company has elected the practical expedient that provides an exemption from the disclosure requirements regarding information about remaining performance obligations on contracts that have original expected durations of one year or less.

Inventory

Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand.

Property, Plant and Equipment

Property, plant and equipment is stated at cost. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method using estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment.

Income per Share

Basic (loss) income per share attributable to Methode is calculated by dividing net (loss) income attributable to Methode by the weighted average number of common shares outstanding for the applicable period, but excludes any contingently issued shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted (loss) income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.

Contingencies

Certain litigation arising in the normal course of business is pending against us. The Company is, from time-to-time, subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, employment-related matters, environmental matters and intellectual property matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the Company's opinion, based on the information available, that it has adequate reserves for these liabilities.

XML

Revenue (Tables)

6 Months Ended

Oct. 28, 2023

Revenue from Contract with Customer [Abstract]

Disaggregated Revenue Information

The following table represents a disaggregation of revenue from contracts with customers by segment and geographical location. Net sales are attributed to regions based on the location of production. Though revenue recognition patterns and contracts are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.

	Three Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	70.9	$	52.0	$	11.7	$	1.5	$	136.1
Europe, the Middle East & Africa ("EMEA")		49.7		42.8		—		—		92.5
Asia		33.7		25.6		—		0.1		59.4
Total net sales	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0
Timing of revenue recognition:
Goods transferred at a point in time	$	149.9	$	120.4	$	11.7	$	1.6	$	283.6
Goods transferred over time		4.4		—		—		—		4.4
Total net sales	$	154.3	$	120.4	$	11.7	$	1.6	$	288.0

	Three Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	97.8	$	40.1	$	14.0	$	1.1	$	153.0
EMEA		53.9		37.9		—		—		91.8
Asia		45.2		25.8		0.1		—		71.1
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9
Timing of revenue recognition:
Goods transferred at a point in time	$	192.3	$	103.8	$	14.1	$	1.1	$	311.3
Goods transferred over time		4.6		—		—		—		4.6
Total net sales	$	196.9	$	103.8	$	14.1	$	1.1	$	315.9

	Six Months Ended October 28, 2023
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	137.7	$	92.0	$	26.9	$	2.3	$	258.9
EMEA		101.9		93.9		—		—		195.8
Asia		73.0		49.9		—		0.1		123.0
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7
Timing of revenue recognition:
Goods transferred at a point in time	$	304.1	$	235.8	$	26.9	$	2.4	$	569.2
Goods transferred over time		8.5		—		—		—		8.5
Total net sales	$	312.6	$	235.8	$	26.9	$	2.4	$	577.7

	Six Months Ended October 29, 2022
(in millions)	Automotive		Industrial		Interface		Medical		Total
Geographic net sales:
North America	$	192.5	$	80.8	$	27.0	$	1.8	$	302.1
EMEA		106.0		66.4		—		—		172.4
Asia		75.0		48.7		0.1		—		123.8
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3
Timing of revenue recognition:
Goods transferred at a point in time	$	364.4	$	195.9	$	27.1	$	1.8	$	589.2
Goods transferred over time		9.1		—		—		—		9.1
Total net sales	$	373.5	$	195.9	$	27.1	$	1.8	$	598.3

XML

Acquisition and Disposition (Tables)

6 Months Ended

Oct. 28, 2023

Acquisitions and Dispositions Disclosure [Abstract]

Preliminary Fair Value and Subsequent Measurement Period Adjustments of Assets Acquired and Liabilities Assumed, Including Reconciliation to Total Purchase Price

The preliminary fair value and subsequent measurement period adjustments of the assets acquired and liabilities assumed, including a reconciliation to the total purchase price, were as follows:

	As reported as of July 29, 2023			Measurement period adjustments			As of October 28, 2023
(in millions)
Cash and cash equivalents	$	19.6		$	—		$	19.6
Accounts receivable		17.1			—			17.1
Inventories		9.6			(0.2	)		9.4
Property, plant and equipment		12.9			3.4			16.3
Identifiable intangible assets		68.1			24.5			92.6
Accounts payable		(10.8	)		—			(10.8	)
Long-term debt		(24.4	)		—			(24.4	)
Other assets and liabilities, net		(2.8	)		(0.5	)		(3.3	)
Deferred tax liabilities		(13.4	)		(5.4	)		(18.8	)
Total identifiable net assets acquired		75.9			21.8			97.7
Goodwill		69.6			(21.8	)		47.8
Total fair value of net assets acquired		145.5			—			145.5
Less: redeemable noncontrolling interest		(11.3	)		—			(11.3	)
Total purchase price	$	134.2		$	—		$	134.2

XML

Income Taxes (Tables)

6 Months Ended

Oct. 28, 2023

Income Tax Disclosure [Abstract]

Schedule of Income Tax (Benefit) Expense And Effective Tax Rate

The Company’s income tax (benefit) expense and effective tax rate for the three and six months ended October 28, 2023 and October 29, 2022 were as follows:

	Three Months Ended						Six Months Ended
($ in millions)	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Pre-tax (loss) income	$	(55.5	)	$	33.4		$	(54.5	)	$	59.3
Income tax (benefit) expense	$	(0.2	)		5.8		$	(0.1	)		10.2
Effective tax rate		0.4	%		17.4	%		0.2	%		17.2	%

XML

Balance Sheet Components (Tables)

6 Months Ended

Oct. 28, 2023

Balance Sheet Components [Abstract]

Summary of Inventories

A summary of inventories is shown below:

(in millions)	October 28, 2023		April 29, 2023
Finished products	$	47.3	$	36.6
Work in process		17.7		14.4
Raw materials		118.9		108.7
Total inventories	$	183.9	$	159.7

Summary of Property, Plant and Equipment

A summary of property, plant and equipment is shown below:

(in millions)	October 28, 2023			April 29, 2023
Land	$	3.0		$	3.0
Buildings and building improvements		99.5			98.8
Machinery and equipment		411.4			414.3
Construction in progress		48.0			40.6
Total property, plant and equipment, gross		561.9			556.7
Less: accumulated depreciation		(337.3	)		(336.4	)
Property, plant and equipment, net	$	224.6		$	220.3

XML

Goodwill and Other Intangible Assets (Tables)

6 Months Ended

Oct. 28, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of the Changes in the Carrying Amount of Goodwill by Segment

A summary of the changes in the carrying amount of goodwill, by segment, is shown below:

(in millions)	Automotive			Industrial			Total
Balance as of April 29, 2023	$	106.2		$	195.7		$	301.9
Acquisition (Note 3)		—			(21.8	)		(21.8	)
Impairment		(56.5	)		—			(56.5	)
Foreign currency translation		(0.3	)		(2.6	)		(2.9	)
Balance as of October 28, 2023	$	49.4		$	171.3		$	220.7

Summary of Goodwill by Reporting Unit

A summary of goodwill by reporting unit is as follows:

(in millions)	October 28, 2023		April 29, 2023
Grakon Industrial	$	123.9	$	124.5
North American Automotive		49.4		99.8
Nordic Lights		45.8		69.6
European Automotive		—		6.4
Other		1.6		1.6
Total	$	220.7	$	301.9

Schedule of Other Intangible Assets, Net

Details of identifiable intangible assets are shown below:

	As of October 28, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	303.6	$	(76.1	)	$	227.5		15.2
Trade names, patents and technology licenses		74.0		(38.6	)		35.4		7.1
Total amortized intangible assets		377.6		(114.7	)		262.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	379.4	$	(114.7	)	$	264.7

	As of April 29, 2023
(in millions)	Gross		Accumulated amortization			Net		Weighted average remaining useful life (years)
Amortized intangible assets:
Customer relationships and agreements	$	286.7	$	(68.2	)	$	218.5		14.8
Trade names, patents and technology licenses		71.6		(35.2	)		36.4		6.0
Total amortized intangible assets		358.3		(103.4	)		254.9
Unamortized trade name		1.8		—			1.8
Total other intangible assets	$	360.1	$	(103.4	)	$	256.7

Schedule of Estimated Aggregate Amortization Expense of Intangible Assets

Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:

(in millions)
Fiscal Year:
Remainder of 2024	$	11.8
2025		23.1
2026		22.2
2027		21.6
2028		19.3
Thereafter		164.9
Total	$	262.9

XML

Derivative Instruments and Hedging Activities (Tables)

6 Months Ended

Oct. 28, 2023

Text Block [Abstract]

Schedule of Fair Value of Derivative Instruments Classified as Level 2 Within Fair Value Recorded in the Balance Sheet

The fair value of derivative instruments are classified as Level 2 within the fair value hierarchy and are recorded in the balance sheets as follows:

		Asset/(Liability)
(in millions)	Financial Statement Caption	October 28, 2023			April 29, 2023
Derivatives designated as hedging instruments:
Net investment hedges	Other accrued liabilities	$	—		$	(0.5	)
Interest rate swaps	Prepaid expenses and other current assets	$	—		$	1.6
Interest rate swaps	Other long-term liabilities	$	(1.1	)	$	—
Derivatives not designated as hedging instruments:
Foreign currency forward contracts	Prepaid expenses and other current assets	$	—		$	0.1
Foreign currency forward contracts	Other accrued liabilities	$	(0.1	)	$	(0.1	)

Schedule of Derivative Instruments Effect on Other Comprehensive Income (Loss)

Gross amounts recorded in other comprehensive income (loss) were as follows:

	Three Months Ended					Six Months Ended
(in millions)	October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Net investment hedges	$	1.1		$	1.4	$	1.2		$	3.4
Interest rate swaps		(0.4	)		0.7		(2.7	)		0.7
Total	$	0.7		$	2.1	$	(1.5	)	$	4.1

XML

Debt (Tables)

6 Months Ended

Oct. 28, 2023

Debt Disclosure [Abstract]

Summary of Debt

A summary of debt is shown below:

(in millions)	October 28, 2023			April 29, 2023
Revolving credit facility	$	330.6		$	305.4
Other debt		4.4			4.7
Unamortized debt issuance costs		(3.0	)		(3.3	)
Total debt		332.0			306.8
Less: current maturities		(3.0	)		(3.2	)
Total long-term debt	$	329.0		$	303.6

XML

Shareholders' Equity (Tables)

6 Months Ended

Oct. 28, 2023

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Stock Buyback Activity Under Share Buyback Program

The following table summarizes the Company’s stock buyback activity under this share buyback program:

	Three Months Ended				Six Months Ended
(in millions, except share and per share data)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Shares purchased		322,779		508,179		322,779		825,814
Average price per share	$	24.03	$	38.69	$	24.03	$	38.21
Total cost	$	7.8	$	19.7	$	7.8	31.6

Summary of Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax

A summary of changes in AOCI, net of tax is shown below:

	Three Months Ended October 28, 2023									Six Months Ended October 28, 2023
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(22.3	)	$	(0.8	)	$	(23.1	)	$	(19.8	)	$	0.8		$	(19.0	)
Other comprehensive income (loss)		(17.6	)		0.7			(16.9	)		(20.3	)		(1.5	)		(21.8	)
Tax (expense) benefit		(2.6	)		(0.3	)		(2.9	)		(2.4	)		0.3			(2.1	)
Net other comprehensive income (loss)		(20.2	)		0.4			(19.8	)		(22.7	)		(1.2	)		(23.9	)
Balance at the end of period	$	(42.5	)	$	(0.4	)	$	(42.9	)	$	(42.5	)	$	(0.4	)	$	(42.9	)

	Three Months Ended October 29, 2022									Six Months Ended October 29, 2022
(in millions)	Currency translation adjustments			Derivative instruments			Total			Currency translation adjustments			Derivative instruments			Total
Balance at beginning of period	$	(41.4	)	$	5.2		$	(36.2	)	$	(30.5	)	$	3.7		$	(26.8	)
Other comprehensive income (loss)		(19.9	)		2.1			(17.8	)		(30.8	)		4.1			(26.7	)
Tax (expense) benefit		0.2			(0.5	)		(0.3	)		0.2			(1.0	)		(0.8	)
Net other comprehensive income (loss)		(19.7	)		1.6			(18.1	)		(30.6	)		3.1			(27.5	)
Balance at the end of period	$	(61.1	)	$	6.8		$	(54.3	)	$	(61.1	)	$	6.8		$	(54.3	)

Summary of RSA and RSU Activity

The following table summarizes RSA activity:

	Restricted stock awards		Weighted average grant date fair value
Non-vested at April 29, 2023		933,674	$	28.73
Awarded		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Non-vested at October 28, 2023		933,674	$	28.73

The following table summarizes RSU activity:

	Restricted stock units			Weighted average grant date fair value
Non-vested at April 29, 2023		727,467		$	30.60
Awarded		207,050		$	22.83
Vested		(866	)	$	38.24
Forfeited		(13,474	)	$	41.62
Non-vested at October 28, 2023		920,177		$	28.68

Summary of Awards Granted to Non-employee Directors

The following table summarizes awards granted to non-employee directors:

	Non-employee director awards			Deferred non-employee director awards		Total			Weighted average grant date fair value
Outstanding at April 29, 2023		—			45,750		45,750		$	40.56
Awarded		16,804			30,194		46,998		$	33.22
Issued		(16,804	)		—		(16,804	)	$	33.32
Outstanding at October 28, 2023		—			75,944		75,944		$	37.62

Summary of combined stock option activity and related information for stock options granted

The following table summarizes stock option activity:

	Stock options		Weighted average exercise price		Weighted- average life (years)		Aggregate intrinsic value (in millions)
Outstanding and exercisable at April 29, 2023		20,000	$	37.01		1.2	$	0.1
Exercised		—	$	—
Forfeited		—	$	—
Outstanding and exercisable at October 28, 2023		20,000	$	37.01		0.7	$	0.0

Summary of Stock-based Compensation Expense Related to Equity Awards

The table below summarizes the stock-based compensation expense related to the equity awards:

	Three Months Ended				Six Months Ended
(in millions)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
RSUs	$	1.3	$	2.7	$	2.3	$	5.1
Deferred non-employee director awards		—		—		1.0		1.0
Non-employee director awards		—		—		0.6		0.6
Total stock-based compensation expense	$	1.3	$	2.7	$	3.9	$	6.7

XML

(Loss) Income per Share (Tables)

6 Months Ended

Oct. 28, 2023

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Income per Share

The following table sets forth the computation of basic and diluted (loss) income per share attributable to Methode:

	Three Months Ended					Six Months Ended
	October 28, 2023			October 29, 2022		October 28, 2023			October 29, 2022
Numerator:
Net (loss) income attributable to Methode (in millions)	$	(55.3	)	$	27.6	$	(54.4	)	$	49.1
Denominator:
Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units		35,671,677			36,126,132		35,679,776			36,346,054
Dilutive potential common shares		—			715,699		—			682,762
Denominator for diluted income per share		35,671,677			36,841,831		35,679,776			37,028,816
(Loss) income per share attributable to Methode:
Basic	$	(1.55	)	$	0.76	$	(1.52	)	$	1.35
Diluted	$	(1.55	)	$	0.75	$	(1.52	)	$	1.33
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding		1,543,183			940,510		1,536,206			934,522

XML

Segment Information (Tables)

6 Months Ended

Oct. 28, 2023

Segment Reporting [Abstract]

Schedule of Reportable Segments

The tables below present information about the Company’s reportable segments:

	Three Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations/ Corporate			Consolidated
Net sales	$	158.0		$	128.0		$	11.7	$	1.6		$	(11.3	)	$	288.0
Transfers between segments		(3.7	)		(7.6	)		—		—			11.3			—
Net sales to unaffiliated customers	$	154.3		$	120.4		$	11.7	$	1.6		$	—		$	288.0
Income (loss) from operations	$	(61.5	)	$	25.7		$	1.0	$	(0.7	)	$	(15.8	)	$	(51.3	)
Interest expense, net																4.4
Other income, net																(0.2	)
Pre-tax loss															$	(55.5	)
Goodwill impairment	$	56.5		$	—		$	—	$	—		$	—		$	56.5

	Three Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	198.3		$	107.8		$	14.1	$	1.1		$	(5.4	)	$	315.9
Transfers between segments		(1.4	)		(4.0	)		—		—			5.4			—
Net sales to unaffiliated customers	$	196.9		$	103.8		$	14.1	$	1.1		$	—		$	315.9
Income (loss) from operations	$	23.4		$	25.0		$	1.6	$	(1.4	)	$	(15.8	)	$	32.8
Interest expense, net																0.5
Other income, net																(1.1	)
Pre-tax income															$	33.4

	Six Months Ended October 28, 2023
(in millions)	Automotive			Industrial			Interface			Medical			Eliminations/ Corporate			Consolidated
Net sales	$	319.1		$	250.6		$	27.0		$	2.4		$	(21.4	)	$	577.7
Transfers between segments		(6.5	)		(14.8	)		(0.1	)		—			21.4			—
Net sales to unaffiliated customers	$	312.6		$	235.8		$	26.9		$	2.4		$	—		$	577.7
Income (loss) from operations	$	(64.3	)	$	49.9		$	3.9		$	(2.9	)	$	(34.1	)	$	(47.5	)
Interest expense, net																	7.2
Other income, net																	(0.2	)
Pre-tax loss																$	(54.5	)
Goodwill impairment	$	56.5		$	—		$	—		$	—		$	—		$	56.5

	Six Months Ended October 29, 2022
(in millions)	Automotive			Industrial			Interface		Medical			Eliminations /Corporate			Consolidated
Net sales	$	375.6		$	201.5		$	27.1	$	1.8		$	(7.7	)	$	598.3
Transfers between segments		(2.1	)		(5.6	)		—		—			7.7			—
Net sales to unaffiliated customers	$	373.5		$	195.9		$	27.1	$	1.8		$	—		$	598.3
Income (loss) from operations	$	38.1		$	47.4		$	3.2	$	(2.9	)	$	(31.2	)	$	54.6
Interest expense, net																0.5
Other income, net																(5.2	)
Pre-tax income															$	59.3

(in millions)	October 28, 2023		April 29, 2023
Identifiable assets:
Automotive	$	643.3	$	700.2
Industrial		636.8		672.3
Interface		117.5		127.2
Medical		0.8		6.2
Eliminations/Corporate		86.5		73.2
Total identifiable assets	$	1,484.9	$	1,579.1

XML

Restructuring (Tables)

6 Months Ended

Oct. 28, 2023

Restructuring and Related Activities [Abstract]

Summary of Components of Restructuring Costs

Components of restructuring costs were as follows:

	Three Months Ended				Six Months Ended
(in millions)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Automotive	$	0.2	$	—	$	0.2	$	—
Industrial		—		0.4		—		0.5
Interface		—		—		—		—
Medical		0.4		—		1.1		—
Eliminations/Corporate		—		0.1		—		0.1
Total restructuring costs	$	0.6	$	0.5	$	1.3	$	0.6
Recognized in:
Cost of products sold	$	0.2	$	0.1	$	0.8	$	0.1
Selling and administrative expenses		0.4		0.4		0.5		0.5
	$	0.6	$	0.5	$	1.3	$	0.6

XML

Description of Business and Summary of Significant Accounting Policies (Details)	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Fiscal period duration	91 days	91 days	182 days	182 days
ASU 2021-08
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adopted [true false]	true		true
Change in accounting principle, accounting standards update, immaterial effect [true false]	true		true

XML

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 288.0	$ 315.9	$ 577.7	$ 598.3
Automotive
Disaggregation of Revenue [Line Items]
Net sales	154.3	196.9	312.6	373.5
Industrial
Disaggregation of Revenue [Line Items]
Net sales	120.4	103.8	235.8	195.9
Interface
Disaggregation of Revenue [Line Items]
Net sales	11.7	14.1	26.9	27.1
Medical
Disaggregation of Revenue [Line Items]
Net sales	1.6	1.1	2.4	1.8
Goods Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Net sales	283.6	311.3	569.2	589.2
Goods Transferred at a Point in Time | Automotive
Disaggregation of Revenue [Line Items]
Net sales	149.9	192.3	304.1	364.4
Goods Transferred at a Point in Time | Industrial
Disaggregation of Revenue [Line Items]
Net sales	120.4	103.8	235.8	195.9
Goods Transferred at a Point in Time | Interface
Disaggregation of Revenue [Line Items]
Net sales	11.7	14.1	26.9	27.1
Goods Transferred at a Point in Time | Medical
Disaggregation of Revenue [Line Items]
Net sales	1.6	1.1	2.4	1.8
Goods Transferred Over Time
Disaggregation of Revenue [Line Items]
Net sales	4.4	4.6	8.5	9.1
Goods Transferred Over Time | Automotive
Disaggregation of Revenue [Line Items]
Net sales	4.4	4.6	8.5	9.1
North America
Disaggregation of Revenue [Line Items]
Net sales	136.1	153.0	258.9	302.1
North America | Automotive
Disaggregation of Revenue [Line Items]
Net sales	70.9	97.8	137.7	192.5
North America | Industrial
Disaggregation of Revenue [Line Items]
Net sales	52.0	40.1	92.0	80.8
North America | Interface
Disaggregation of Revenue [Line Items]
Net sales	11.7	14.0	26.9	27.0
North America | Medical
Disaggregation of Revenue [Line Items]
Net sales	1.5	1.1	2.3	1.8
EMEA
Disaggregation of Revenue [Line Items]
Net sales	92.5	91.8	195.8	172.4
EMEA | Automotive
Disaggregation of Revenue [Line Items]
Net sales	49.7	53.9	101.9	106.0
EMEA | Industrial
Disaggregation of Revenue [Line Items]
Net sales	42.8	37.9	93.9	66.4
Asia
Disaggregation of Revenue [Line Items]
Net sales	59.4	71.1	123.0	123.8
Asia | Automotive
Disaggregation of Revenue [Line Items]
Net sales	33.7	45.2	73.0	75.0
Asia | Industrial
Disaggregation of Revenue [Line Items]
Net sales	25.6	25.8	49.9	48.7
Asia | Interface
Disaggregation of Revenue [Line Items]
Net sales		$ 0.1		$ 0.1
Asia | Medical
Disaggregation of Revenue [Line Items]
Net sales	$ 0.1		$ 0.1

XML

Acquisition and Disposition - Narrative (Details) € in Millions						3 Months Ended		6 Months Ended
	Oct. 13, 2023 USD ($)	Oct. 10, 2023 EUR (€)	Oct. 10, 2023 USD ($)	Apr. 20, 2023 EUR (€)	Apr. 20, 2023 USD ($)	Jul. 31, 2023 EUR (€)	Jul. 31, 2023 USD ($)	Oct. 28, 2023 USD ($)
Dabir Business
Acquisitions and Dispositions [Line Items]
Consideration from sale of business	$ 1,500,000
Loss on the sale of business, including transaction costs	$ (600,000)
Finland | Nordic Lights
Acquisitions and Dispositions [Line Items]
Ownership percentage in subsidiary		100.00%	100.00%
Finland | Nordic Lights | Maximum
Acquisitions and Dispositions [Line Items]
Ownership percentage of minority shareholders					10.00%
Nordic Lights | Finland
Acquisitions and Dispositions [Line Items]
Percentage acquired					92.20%	99.40%	99.40%
Additional percentage acquired		0.60%	0.60%			7.20%	7.20%
Payments to acquire business in cash		€ 0.8	$ 900,000	€ 121.8	$ 134,200,000	€ 9.2	$ 10,200,000
Expected goodwill recognized to be deductible for income tax purposes					$ 0
Weighted average amortization period for acquired intangible assets				18 years 2 months 12 days	18 years 2 months 12 days
Acquisition cost incurred								$ 500,000

XML

Acquisition and Disposition - Preliminary Fair Value and Subsequent Measurement Period Adjustments of Assets Acquired and Liabilities Assumed, Including Reconciliation to Total Purchase Price (Details) - USD ($) $ in Millions	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Goodwill	$ 220.7		$ 301.9
Nordic Lights | Finland
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Cash and cash equivalents	19.6
Accounts receivable	17.1
Inventories	9.4
Property, plant and equipment	16.3
Identifiable intangible assets	92.6
Accounts payable	(10.8)
Long-term debt	(24.4)
Other assets and liabilities, net	(3.3)
Deferred tax liabilities	(18.8)
Total identifiable net assets acquired	97.7
Goodwill	47.8
Total fair value of net assets acquired	145.5
Less: redeemable noncontrolling interest	(11.3)
Total purchase price	134.2
Nordic Lights | Finland | As Reported as of July 29, 2023
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Cash and cash equivalents		$ 19.6
Accounts receivable		17.1
Inventories		9.6
Property, plant and equipment		12.9
Identifiable intangible assets		68.1
Accounts payable		(10.8)
Long-term debt		(24.4)
Other assets and liabilities, net		(2.8)
Deferred tax liabilities		(13.4)
Total identifiable net assets acquired		75.9
Goodwill		69.6
Total fair value of net assets acquired		145.5
Less: redeemable noncontrolling interest		(11.3)
Total purchase price		$ 134.2
Nordic Lights | Finland | Measurement Period Adjustments
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Inventories	(0.2)
Property, plant and equipment	3.4
Identifiable intangible assets	24.5
Other assets and liabilities, net	(0.5)
Deferred tax liabilities	(5.4)
Total identifiable net assets acquired	21.8
Goodwill	$ (21.8)

XML

Income Taxes - Schedule of Income before Income Taxes, Income Tax (Benefit) Expense and Effective Income Tax Rate (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Income Tax Disclosure [Abstract]
Pre-tax (loss) income	$ (55.5)	$ 33.4	$ (54.5)	$ 59.3
Income tax (benefit) expense	$ (0.2)	$ 5.8	$ (0.1)	$ 10.2
Effective tax rate	0.40%	17.40%	0.20%	17.20%

XML

Income Taxes - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022	Apr. 29, 2023
Income Tax Examination [Line Items]
Income tax at statutory rate	21.00%	21.00%	21.00%	21.00%
Gross unrecognized income tax benefits	$ 4.6		$ 4.6		$ 4.5
Income tax penalties and interest accrued	$ 0.3		$ 0.3		$ 0.2

XML

Balance Sheet Components - Cash and Cash Equivalents - Narrative (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents	$ 122.5	$ 157.0
Money Market Accounts
Cash And Cash Equivalents [Line Items]
Cash and cash equivalents	$ 0.2	$ 1.3

XML

Balance Sheet Components - Accounts Receivable and Allowance for Doubtful Accounts - Narrative (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Allowance for doubtful accounts receivable	$ 1.5	$ 1.3

XML

Balance Sheet Components - Summary of Inventories (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished products	$ 47.3	$ 36.6
Work in process	17.7	14.4
Raw materials	118.9	108.7
Total inventories	$ 183.9	$ 159.7

XML

Balance Sheet Components - Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022	Apr. 29, 2023
Property Plant And Equipment [Line Items]
Depreciation	$ 8.2	$ 7.5	$ 16.5	$ 15.1
Capital expenditures recorded in accounts payable			$ 5.6		$ 4.5
Minimum | Buildings and Building Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	5 years		5 years
Minimum | Machinery and Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	3 years		3 years
Maximum | Buildings and Building Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	40 years		40 years
Maximum | Machinery and Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	15 years		15 years

XML

Balance Sheet Components - Property, Plant and Equipment (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Property Plant And Equipment [Line Items]
Total property, plant and equipment, gross	$ 561.9	$ 556.7
Less: accumulated depreciation	(337.3)	(336.4)
Property, plant and equipment, net	224.6	220.3
Land
Property Plant And Equipment [Line Items]
Total property, plant and equipment, gross	3.0	3.0
Buildings and Building Improvements
Property Plant And Equipment [Line Items]
Total property, plant and equipment, gross	99.5	98.8
Machinery and Equipment
Property Plant And Equipment [Line Items]
Total property, plant and equipment, gross	411.4	414.3
Construction In Progress
Property Plant And Equipment [Line Items]
Total property, plant and equipment, gross	$ 48.0	$ 40.6

XML

Balance Sheet Components - Pre-production Tooling Costs Related to Long-term Supply Arrangements - Narrative (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Preproduction Tooling Costs Relatedto Longterm Supply Arrangements [Abstract]
Pre-production costs	$ 44.5	$ 36.1
Preproduction costs related to long-term supply arrangements, asset for molds dies and tools owned	$ 15.6	$ 12.2

XML

Goodwill and Other Intangible Assets - Schedule of Summary of the Changes in the Carrying Amount of Goodwill by Segment (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Oct. 28, 2023	Oct. 28, 2023
Goodwill [Line Items]
Beginning balance		$ 301.9
Acquisitions		21.8
Impairment	$ (56.5)	(56.5)
Foreign currency translation		(2.9)
Ending balance	220.7	220.7
Automotive
Goodwill [Line Items]
Beginning balance		106.2
Impairment	(56.5)	(56.5)
Foreign currency translation		(0.3)
Ending balance	49.4	49.4
Industrial
Goodwill [Line Items]
Beginning balance		195.7
Acquisitions		21.8
Impairment	0.0	0.0
Foreign currency translation		(2.6)
Ending balance	$ 171.3	$ 171.3

XML

Goodwill and Other Intangible Assets - Summary of Goodwill by Reporting Unit (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Goodwill [Line Items]
Goodwill	$ 220.7	$ 301.9
Grakon Industrial
Goodwill [Line Items]
Goodwill	123.9	124.5
North American Automotive
Goodwill [Line Items]
Goodwill	49.4	99.8
Nordic Lights
Goodwill [Line Items]
Goodwill	45.8	69.6
European Automotive
Goodwill [Line Items]
Goodwill		6.4
Other
Goodwill [Line Items]
Goodwill	$ 1.6	$ 1.6

XML

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Oct. 28, 2023	Oct. 28, 2023
Goodwill [Line Items]
Goodwill impairment	$ 56.5	$ 56.5
North American Automotive
Goodwill [Line Items]
Goodwill impairment	50.4	50.4
European Automotive
Goodwill [Line Items]
Goodwill impairment	$ 6.1	$ 6.1

XML

Goodwill and Other Intangible Assets - Schedule of Other Intangible Assets, Net (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Oct. 28, 2023	Apr. 29, 2023
Finite-lived Intangible Assets [Roll Forward]
Gross	$ 377.6	$ 358.3
Accumulated Amortization	(114.7)	(103.4)
Net/Total	262.9	254.9
Other intangible assets, gross	379.4	360.1
Other intangible assets, accumulated amortization	(114.7)	(103.4)
Other intangible assets, net	264.7	256.7
Unamortized Trade Name
Finite-lived Intangible Assets [Roll Forward]
Gross	1.8	1.8
Net	1.8	1.8
Customer Relationships and Agreements
Finite-lived Intangible Assets [Roll Forward]
Gross	303.6	286.7
Accumulated Amortization	(76.1)	(68.2)
Net/Total	$ 227.5	$ 218.5
Weighted average remaining useful life (years)	15 years 2 months 12 days	14 years 9 months 18 days
Trade Names, Patents and Technology Licenses
Finite-lived Intangible Assets [Roll Forward]
Gross	$ 74.0	$ 71.6
Accumulated Amortization	(38.6)	(35.2)
Net/Total	$ 35.4	$ 36.4
Weighted average remaining useful life (years)	7 years 1 month 6 days	6 years

XML

Goodwill and Other Intangible Assets - Schedule of Estimated Aggregate Amortization Expense of Intangible Assets (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 11.8
2025	23.1
2026	22.2
2027	21.6
2028	19.3
Thereafter	164.9
Net/Total	$ 262.9	$ 254.9

XML

Derivative Instruments and Hedging Activities - Narrative Information (Details) € in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023 USD ($)	Oct. 29, 2022 USD ($)	Oct. 28, 2023 USD ($)	Oct. 29, 2022 USD ($)	Oct. 28, 2023 EUR (€)	Apr. 29, 2023 USD ($)
Derivatives, Fair Value [Line Items]
Derivative, maturity date			Aug. 31, 2023
Derivative, notional amount	$ 60.0		$ 60.0		€ 54.8
Gains on derivative	0.4	$ 0.6	1.1	$ 0.9
Transaction gain associated with net investment hedge reported in AOCI	7.5		7.3
Euro-denominated long-term borrowings under Credit Agreement as hedge	290.6		$ 290.6
Interest Rate Swap
Derivatives, Fair Value [Line Items]
Derivative, maturity date			Oct. 31, 2027
Derivative, notional amount	145.5		$ 145.5		€ 132.0
Interest Rate Swap Two
Derivatives, Fair Value [Line Items]
Derivative, maturity date			Aug. 31, 2023
Derivative, notional amount	100.0		$ 100.0
Foreign Exchange Forward
Derivatives, Fair Value [Line Items]
Derivative, notional amount	71.9		71.9			$ 59.9
Gain (loss) on foreign currency derivatives recorded in earnings, net	$ (0.8)	$ (2.4)	(2.7)	$ (2.8)
Cross-Currency Swap
Derivatives, Fair Value [Line Items]
Gains on derivative			$ 0.6

XML

Derivative Instruments and Hedging Activities - Schedule of Fair Value of Derivative Instruments Classified as Level 2 Within Fair Value Recorded in the Balance Sheet (Details) - Level 2 - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Derivatives Designated as Hedging Instruments | Net Investment Hedges | Other Accrued Liabilities
Derivative Instruments, Gain (Loss) [Line Items]
Fair value of derivative instruments assets (liabilities) net		$ (0.5)
Derivatives Designated as Hedging Instruments | Interest Rate Swap | Prepaid Expenses and Other Current Assets
Derivative Instruments, Gain (Loss) [Line Items]
Fair value of derivative instruments assets (liabilities) net		1.6
Derivatives Designated as Hedging Instruments | Interest Rate Swap | Other Long-term Liabilities
Derivative Instruments, Gain (Loss) [Line Items]
Fair value of derivative instruments assets (liabilities) net	$ (1.1)
Derivatives Not Designated as Hedging Instruments | Foreign Exchange Forward | Other Accrued Liabilities
Derivative Instruments, Gain (Loss) [Line Items]
Fair value of derivative instruments assets (liabilities) net	$ (0.1)	(0.1)
Derivatives Not Designated as Hedging Instruments | Foreign Exchange Forward | Prepaid Expenses and Other Current Assets
Derivative Instruments, Gain (Loss) [Line Items]
Fair value of derivative instruments assets (liabilities) net		$ 0.1

XML

Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments Effect on Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Gross amounts recorded in other comprehensive income (loss) Net	$ 0.7	$ 2.1	$ (1.5)	$ 4.1
Net Investment Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Gross amounts recorded in other comprehensive income (loss) Net	1.1	1.4	1.2	3.4
Interest Rate Swap
Derivative Instruments, Gain (Loss) [Line Items]
Gross amounts recorded in other comprehensive income (loss) Net	$ (0.4)	$ 0.7	$ (2.7)	$ 0.7

XML

Debt - Summary of Debt (Details) - USD ($) $ in Millions	Oct. 28, 2023	Apr. 29, 2023
Debt Instrument [Line Items]
Unamortized debt issuance costs	$ (3.0)	$ (3.3)
Total debt	332.0	306.8
Less: current maturities	(3.0)	(3.2)
Long-term debt	329.0	303.6
Revolving Credit Facility
Debt Instrument [Line Items]
Debt	330.6	305.4
Other Debt
Debt Instrument [Line Items]
Debt	4.4	$ 4.7
Less: current maturities	$ (3.0)

XML

Debt - Revolving Credit Facility/Term Loan (Details) - Revolving Credit Facility € in Millions	Oct. 31, 2022 USD ($)	Oct. 28, 2023 USD ($)	Oct. 28, 2023 EUR (€)
Nordic Lights
Debt Instrument [Line Items]
Euro-denominated outstanding borrowings under revolving credit facility		$ 290,600,000	€ 275.0
Euro denominated borrowings
Debt Instrument [Line Items]
Interest rate (as a percent)		5.60%	5.60%
US dollar borrowings
Debt Instrument [Line Items]
Interest rate (as a percent)		7.20%	7.20%
Line of credit | Bank of America, N.A., and Wells Fargo Bank, N.A. [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 750,000,000
Line of credit | Bank of America, N.A.
Debt Instrument [Line Items]
Leverage ratio on pro forma basis	3
Credit agreement termination date	Oct. 31, 2027
Line of credit | Bank of America, N.A. | Base Rate | Maximum
Debt Instrument [Line Items]
Adjusted interest rate	1.25%
Line of credit | Bank of America, N.A. | Base Rate | Minimum
Debt Instrument [Line Items]
Adjusted interest rate	0.375%
Line of credit | Bank of America, N.A. | SOFR Daily Floating Rate Loans | Maximum
Debt Instrument [Line Items]
Adjusted interest rate	2.25%
Line of credit | Bank of America, N.A. | SOFR Daily Floating Rate Loans | Minimum
Debt Instrument [Line Items]
Adjusted interest rate	1.375%
Line of credit | Bank of America, N.A. | Euro Interbank Offered Rate Plus | Maximum
Debt Instrument [Line Items]
Adjusted interest rate	2.25%
Line of credit | Bank of America, N.A. | Euro Interbank Offered Rate Plus | Minimum
Debt Instrument [Line Items]
Adjusted interest rate	1.375%
Term loan | Bank of America, N.A.
Debt Instrument [Line Items]
Increase in revolving commitments	$ 250,000,000

XML

Debt - Other Debt (Details) $ in Millions	6 Months Ended
	Oct. 28, 2023 USD ($) Note	Apr. 29, 2023 USD ($)
Debt Instrument [Line Items]
Debt, short-term	$ 3.0	$ 3.2
Other Debt
Debt Instrument [Line Items]
Number of notes | Note	3
Weighted-average interest rate (as a percent)	1.40%
Debt, short-term	$ 3.0

XML

Shareholders' Equity - Share Repurchase Program (Details) $ in Millions	Oct. 28, 2023 USD ($) shares
Equity Class Of Treasury Stock [Line Items]
Shares purchased | shares	3,113,154
Stock repurchase cost	$ 127.1
Remaining authorized repurchase amount	72.9
Maximum
Equity Class Of Treasury Stock [Line Items]
Stock repurchase program, Authorized amount	$ 200.0

XML

Shareholders' Equity - Summary of Stock Buyback Activity Under Share Buyback Program (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Share-Based Payment Arrangement [Abstract]
Shares purchased	322,779	508,179	322,779	825,814
Average price per share	$ 24.03	$ 38.69	$ 24.03	$ 38.21
Total cost	$ 7.8	$ 19.7	$ 7.8	$ 31.6

XML

Shareholders' Equity - Dividends (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Cash dividends	$ 4.8	$ 4.9	$ 10.1	$ 9.9
RSAs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Cash dividends			$ 0.4

XML

Shareholders' Equity - Summary of Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	$ 931.4	$ 911.4	$ 941.8	$ 913.8
Other comprehensive income (loss)	(16.9)	(17.8)	(21.8)	(26.7)
Tax (expense) benefit	(2.9)	(0.3)	(2.1)	(0.8)
Net other comprehensive income (loss)	(19.8)	(18.1)	(23.9)	(27.5)
Ending balance	844.9	898.8	844.9	898.8
Currency Translation Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	(22.3)	(41.4)	(19.8)	(30.5)
Other comprehensive income (loss)	(17.6)	(19.9)	(20.3)	(30.8)
Tax (expense) benefit	(2.6)	0.2	(2.4)	0.2
Net other comprehensive income (loss)	(20.2)	(19.7)	(22.7)	(30.6)
Ending balance	(42.5)	(61.1)	(42.5)	(61.1)
Derivative Instruments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	(0.8)	5.2	0.8	3.7
Other comprehensive income (loss)	0.7	2.1	(1.5)	4.1
Tax (expense) benefit	(0.3)	(0.5)	0.3	(1.0)
Net other comprehensive income (loss)	0.4	1.6	(1.2)	3.1
Ending balance	(0.4)	6.8	(0.4)	6.8
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	(23.1)	(36.2)	(19.0)	(26.8)
Net other comprehensive income (loss)	(19.8)	(18.1)	(23.9)	(27.5)
Ending balance	$ (42.9)	$ (54.3)	$ (42.9)	$ (54.3)

XML

Shareholders' Equity - General (Details) - shares	6 Months Ended
	Oct. 28, 2023	Sep. 14, 2022
2014 Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares common stock subject an option granted		1
Number of shares common stock subject an other than option granted		2.28
2022 Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for award (in shares)	4,943,780	5,550,000
Stock-based compensation, description	the number of shares of the Company's common stock that will be available for all awards under the 2022 Plan is 5,550,000, less one share for every one share of common stock subject to an option or SAR award granted after April 30, 2022 under the 2014 Plan and 2.28 shares for every one share that was subject to an award other than an option or SAR granted after April 30, 2022 under the 2014 Plan. As of October 28, 2023, there were 4,943,780 shares available for award under the 2022 Plan.

XML

Shareholders' Equity - Narrative (Details) $ in Millions	6 Months Ended
	Oct. 28, 2023 USD ($) shares
RSAs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares granted in period (in shares)	933,674
Additional stock issuable, shares	466,837
Unrecognized stock-based compensation cost | $	$ 26.8
RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Deferred RSU's	577,055
Minimum | RSAs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting percentage	0.00%
Maximum | RSAs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting percentage	100.00%
Maximum | RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	5 years

XML

Shareholders' Equity - Summary of Restricted Stock Awards and Restricted Stock Units Activity (Details)	6 Months Ended
	Oct. 28, 2023 $ / shares shares
RSAs | Management | 2020 EBITDA Maximum Performance
Shares
Non-vested Outstanding beginning balance (in shares) | shares	933,674
Non-vested Outstanding ending balance (in shares) | shares	933,674
Weighted average grant date fair value
Weighted average grant date fair value - beginning balance (in dollars per share) | $ / shares	$ 28.73
Weighted average grant date fair value - ending balance (in dollars per share) | $ / shares	$ 28.73
RSUs
Shares
Non-vested Outstanding beginning balance (in shares) | shares	727,467
Awarded (in shares) | shares	207,050
Vested (in shares) | shares	(866)
Forfeited (in shares) | shares	(13,474)
Non-vested Outstanding ending balance (in shares) | shares	920,177
Weighted average grant date fair value
Weighted average grant date fair value - beginning balance (in dollars per share) | $ / shares	$ 30.6
Weighted average value, awarded (in dollars per share) | $ / shares	22.83
Weighted average value, vested (in dollars per share) | $ / shares	38.24
Weighted average value, forfeited (in dollars per share) | $ / shares	41.62
Weighted average grant date fair value - ending balance (in dollars per share) | $ / shares	$ 28.68

XML

Shareholders' Equity - Summary of Awards Granted to Non-employee Directors (Details) - Non-employee Directors	6 Months Ended
	Oct. 28, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested Outstanding beginning balance (in shares)	45,750
Awarded (in shares)	46,998
Issued (in shares)	(16,804)
Non-vested Outstanding ending balance (in shares)	75,944
Weighted average grant date fair value
Weighted average grant date fair value - beginning balance (in dollars per share) | $ / shares	$ 40.56
Weighted average grant date fair value, awarded (in dollars per share) | $ / shares	33.22
Weighted average grant date fair value, issued (in dollars per share) | $ / shares	33.32
Weighted average grant date fair value - ending balance (in dollars per share) | $ / shares	$ 37.62
Non-Employee Director Awards
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awarded (in shares)	16,804
Issued (in shares)	(16,804)
Deferred Non-Employee Director Awards
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested Outstanding beginning balance (in shares)	45,750
Awarded (in shares)	30,194
Non-vested Outstanding ending balance (in shares)	75,944

XML

Shareholders' Equity - Summary of Combined Stock Option Activity and Related Information for Stock Options Granted (Details) - Share-based Payment Arrangement, Option - USD ($) $ / shares in Units, $ in Millions	6 Months Ended	12 Months Ended
	Oct. 28, 2023	Apr. 29, 2023
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding [Roll Forward]
Outstanding - beginning balance (in shares)	20,000
Outstanding - ending balance (in shares)	20,000	20,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price, Outstanding - beginning balance (in dollars per share)	$ 37.01
Weighted average exercise price, Outstanding - ending balance (in dollars per share)	$ 37.01	$ 37.01
Weighted-average life of outstanding options	8 months 12 days	1 year 2 months 12 days
Intrinsic value of outstanding options	$ 0.0	$ 0.1

XML

Shareholders' Equity - Stock-based Compensation Expense (Details) - 2014 Incentive Plan - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	$ 1.3	$ 2.7	$ 3.9	$ 6.7
RSUs | Management
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	$ 1.3	$ 2.7	2.3	5.1
RSUs | Non-employee Directors
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			0.6	0.6
RSUs | Deferred Non-Employee Director Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			$ 1.0	$ 1.0

XML

(Loss) Income per Share - Schedule of Computation of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Earnings Per Share [Abstract]
Net Income (Loss)	$ (55.3)	$ 27.6	$ (54.4)	$ 49.1
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units	35,671,677	36,126,132	35,679,776	36,346,054
Dilutive potential common shares		715,699		682,762
Denominator for diluted income per share	35,671,677	36,841,831	35,679,776	37,028,816
(Loss) income per share attributable to Methode:
Basic	$ (1.55)	$ 0.76	$ (1.52)	$ 1.35
(Loss) income per share attributable to Methode:
Diluted	$ (1.55)	$ 0.75	$ (1.52)	$ 1.33
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding	1,543,183	940,510	1,536,206	934,522

XML

(Loss) Income per Share - Narrative (Details) - shares	3 Months Ended	6 Months Ended
	Oct. 28, 2023	Oct. 28, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effect of potential common shares	584,000	589,000

XML

Segment Information - Narrative (Details)	6 Months Ended
	Oct. 28, 2023 Segment
Segment Reporting [Abstract]
Number of reportable segments	4

XML

Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022	Apr. 29, 2023
Segment Reporting Information [Line Items]
Net sales	$ 288.0	$ 315.9	$ 577.7	$ 598.3
Income (loss) from operations	(51.3)	32.8	(47.5)	54.6
Interest expense, net	4.4	0.5	7.2	0.5
Other expense (income), net	(0.2)	(1.1)	(0.2)	(5.2)
Pre-tax (loss) income	(55.5)	33.4	(54.5)	59.3
Goodwill impairment	56.5		56.5
Identifiable assets	1,484.9		1,484.9		$ 1,579.1
Automotive
Segment Reporting Information [Line Items]
Net sales	154.3	196.9	312.6	373.5
Income (loss) from operations	(61.5)	23.4	(64.3)	38.1
Goodwill impairment	56.5		56.5
Identifiable assets	643.3		643.3		700.2
Industrial
Segment Reporting Information [Line Items]
Net sales	120.4	103.8	235.8	195.9
Income (loss) from operations	25.7	25.0	49.9	47.4
Goodwill impairment	0.0		0.0
Identifiable assets	636.8		636.8		672.3
Interface
Segment Reporting Information [Line Items]
Net sales	11.7	14.1	26.9	27.1
Income (loss) from operations	1.0	1.6	3.9	3.2
Goodwill impairment	0.0		0.0
Identifiable assets	117.5		117.5		127.2
Medical
Segment Reporting Information [Line Items]
Net sales	1.6	1.1	2.4	1.8
Income (loss) from operations	(0.7)	(1.4)	(2.9)	(2.9)
Goodwill impairment	0.0		0.0
Identifiable assets	0.8		0.8		6.2
Eliminations/Corporate
Segment Reporting Information [Line Items]
Net sales	0.0	0.0	0.0	0.0
Income (loss) from operations	(15.8)	(15.8)	(34.1)	(31.2)
Goodwill impairment	0.0		0.0
Identifiable assets	86.5		86.5		$ 73.2
Operating Segments
Segment Reporting Information [Line Items]
Net sales	288.0	315.9	577.7	598.3
Operating Segments | Automotive
Segment Reporting Information [Line Items]
Net sales	158.0	198.3	319.1	375.6
Operating Segments | Industrial
Segment Reporting Information [Line Items]
Net sales	128.0	107.8	250.6	201.5
Operating Segments | Interface
Segment Reporting Information [Line Items]
Net sales	11.7	14.1	27.0	27.1
Operating Segments | Medical
Segment Reporting Information [Line Items]
Net sales	1.6	1.1	2.4	1.8
Operating Segments | Eliminations/Corporate
Segment Reporting Information [Line Items]
Net sales	(11.3)	(5.4)	(21.4)	(7.7)
Transfers between Segments
Segment Reporting Information [Line Items]
Net sales	0.0	0.0	0.0	0.0
Transfers between Segments | Automotive
Segment Reporting Information [Line Items]
Net sales	(3.7)	(1.4)	(6.5)	(2.1)
Transfers between Segments | Industrial
Segment Reporting Information [Line Items]
Net sales	(7.6)	(4.0)	(14.8)	(5.6)
Transfers between Segments | Interface
Segment Reporting Information [Line Items]
Net sales	0.0	0.0	(0.1)	0.0
Transfers between Segments | Medical
Segment Reporting Information [Line Items]
Net sales	0.0	0.0	0.0	0.0
Transfers between Segments | Eliminations/Corporate
Segment Reporting Information [Line Items]
Net sales	$ 11.3	$ 5.4	$ 21.4	$ 7.7

XML

Contingencies - Narrative (Details) $ in Millions	Mar. 02, 2020 USD ($)
Compensatory Damages
Loss Contingencies [Line Items]
Gain Contingency, Unrecorded Amount	$ 102
Punitive Damages
Loss Contingencies [Line Items]
Gain Contingency, Unrecorded Amount	$ 11

XML

Restructuring - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Oct. 28, 2023	Oct. 28, 2023	Oct. 29, 2022
Restructuring Cost And Reserve [Line Items]
Asset impairment charges		$ 0.6	$ 0.4
Restructuring liability	$ 0.1	0.1
Automotive
Restructuring Cost And Reserve [Line Items]
Severance costs	0.2	0.2
Selling and Administrative Expenses
Restructuring Cost And Reserve [Line Items]
Severance costs	$ 0.4	$ 0.5

XML

Restructuring - Summary of Components of Restructuring Costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring Costs	$ 0.6	$ 0.5	$ 1.3	$ 0.6
Cost of Products Sold
Restructuring Cost and Reserve [Line Items]
Restructuring Costs	0.2	0.1	0.8	0.1
Selling and Administrative Expenses
Restructuring Cost and Reserve [Line Items]
Restructuring Costs	0.4	0.4	0.5	0.5
Automotive
Restructuring Cost and Reserve [Line Items]
Restructuring Costs	0.2		0.2
Industrial
Restructuring Cost and Reserve [Line Items]
Restructuring Costs		0.4		0.5
Medical
Restructuring Cost and Reserve [Line Items]
Restructuring Costs	$ 0.4		$ 1.1
Eliminations/Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring Costs		$ 0.1		$ 0.1